WO2021235551A1 - Method for determining resistance against skin aging using genetic polymorphism - Google Patents

Method for determining resistance against skin aging using genetic polymorphism Download PDF

Info

Publication number
WO2021235551A1
WO2021235551A1 PCT/JP2021/019452 JP2021019452W WO2021235551A1 WO 2021235551 A1 WO2021235551 A1 WO 2021235551A1 JP 2021019452 W JP2021019452 W JP 2021019452W WO 2021235551 A1 WO2021235551 A1 WO 2021235551A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
group
snp
power
resistance
Prior art date
Application number
PCT/JP2021/019452
Other languages
French (fr)
Japanese (ja)
Inventor
智恵子 水本
聡 天野
達也 吉川
美星 横尾
直人 羽生
Original Assignee
株式会社 資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社 資生堂 filed Critical 株式会社 資生堂
Priority to JP2022524553A priority Critical patent/JPWO2021235551A1/ja
Publication of WO2021235551A1 publication Critical patent/WO2021235551A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/34Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor

Definitions

  • the present invention relates to a method for determining resistance to skin aging based on a genetic test, a control program for an evaluation system for skin aging resistance, and a control program for a skin aging resistance evaluation system. Skin counseling is possible based on the method, system, and program for determining the resistance of the skin to aging of the present invention.
  • the skin test based on SNP analysis is performed based on a statistical method between the genetic information regarding the subject's SNP and the measurement data of the skin condition.
  • the skin quality determined based on the subject's SNP information corresponds to the skin condition measurement data used in the statistical method, but the problem is that there is a discrepancy with the evaluation of the skin condition felt by the subject. It has become.
  • the reason is that the skin condition changes not only according to the genetic background but also according to the acquired environmental factors, and the evaluation of the skin quality based on the SNP analysis does not necessarily represent the current skin condition of the subject. Can be mentioned.
  • the results of the genetic test reflect the genetic background of the individual, there is a problem that the subject who has undergone the genetic test gives up that the gene cannot be changed.
  • the present inventors have conducted diligent research on such a problem, and have come to develop a method for evaluating the result of SNP analysis from the viewpoint of resistance to skin aging, instead of using it for evaluation of skin condition.
  • the SNP selected in the present invention is a learning model learned from genetic information, environmental information, and actual skin measurement data, and is generated by a learning model that outputs the skin constitution when genetic information and environmental information are input. This is the SNP adopted in the aging model formula. Therefore, the SNP selected in the present invention is an SNP having a great influence on the aging susceptibility of the skin. It is considered that one of the factors that the skin is easy to age is the low resistance to aging.
  • the SNP selected in the present invention is an SNP having a great influence on the resistance of the skin to aging.
  • the resistance of the skin to aging which is the result of the analysis of the SNPs selected in this way, is an evaluation item corresponding to the genetic background.
  • a method for determining the resistance to skin aging based on SNP in a gene involved in the resistance to skin aging [2] The method according to item 1, wherein the aging of the skin is selected from aging caused by lifestyle, aging caused by the external environment, and natural aging caused by aging. [3] The resistance to aging of the skin is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization.
  • the method according to item 1 or 2 wherein the method is at least 1 selected from the group consisting of forces.
  • BLMH bleomycin hydrolase
  • CASP14 caspase 14
  • HAS3 hyaluronan synthase 3
  • At least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862 determines the resistance to skin aging for cell activity.
  • the resistance to skin aging with respect to skin shielding is determined by at least one SNP selected from the group consisting of rs2158467, rs2227564, rs2227566, rs2227568, rs2227574, rs3181162, rs4065, rs717309, and rs8110862.
  • Method. [8] Face shape modeling ability is determined based on SNPs in at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1. Or the method according to 3.
  • the resistance to skin aging is rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884.
  • the SNPs selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061 determine the resistance of skin to aging with respect to metabolic maintenance, according to item 10.
  • Method. The method according to item 2 or 3, wherein the skin color assisting force is determined based on SNP in at least one gene selected from the group consisting of OCA2 and IRF4.
  • At least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071 determines the resistance to skin aging with respect to skin color assisting power, item 12. The method described. [14] The method according to item 2 or 3, wherein the stimulus protection force is determined based on the SNP in at least one gene selected from the group consisting of SOD2 and GPX1.
  • the resistance to aging of the skin is a stimulus-protecting force
  • the following: At least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164 determines the resistance to skin aging with respect to irritation protection, in item 14. The method described.
  • the method of item 2 or 3 wherein the damage control force is determined based on the SNP in at least one gene selected from the group consisting of TNF- ⁇ , PLAU (uPA), and TNFR2.
  • At least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184 provides resistance to skin aging for oil vitamin utilization.
  • the method according to item 20 which is determined.
  • a method for proposing preventive measures against aging according to the resistance determined by the method according to any one of items 1 to 21.
  • a device for determining the resistance of skin to aging Input section for inputting SNP information about genes involved in skin aging resistance, A storage unit that stores the relationship between SNP information and the resistance of the skin to aging in advance. A processing unit that compares the SNP information input from the input unit with the relationship between the SNP information stored in the storage unit in advance and the resistance to skin aging, and determines the resistance to skin aging.
  • the determination device comprising an output unit that outputs a determined resistance to skin aging.
  • the resistance to aging of the skin is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization.
  • the gene involved in cell active force is at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
  • the gene involved in the skin shielding force is at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
  • the gene involved in face shape modeling ability is at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1.
  • the gene involved in metabolic maintenance is at least one gene selected from the group consisting of VEGFA and VEGFC.
  • the gene involved in skin color assisting power is at least one gene selected from the group consisting of OCA2 and IRF4.
  • the gene involved in stimulus protection is at least one gene selected from the group consisting of SOD2 and GPX1.
  • the gene involved in damage control is at least one gene selected from the group consisting of TNF- ⁇ , PLAU (uPA), and TNFR2.
  • the gene involved in aquavitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood, and the gene involved in oil vitamin utilization is in the blood. 25.
  • SNP information on genes involved in cell active force is as follows: Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
  • SNP information about genes involved in skin shielding is as follows: Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
  • SNP information about genes involved in face shape modeling ability is as follows: rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Information about at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509.
  • SNP information about genes involved in metabolic maintenance is as follows: Information about at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061.
  • SNP information about genes involved in skin color assisting power is as follows: Information about at least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071.
  • SNP information about genes involved in stimulus protection is as follows: Information about at least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164.
  • SNP information about genes involved in damage control is as follows: Information about at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673.
  • SNP information on genes involved in aquavitamin utilization is as follows: Information about at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
  • SNP information on genes involved in oil-vitamin utilization is as follows: The decision according to item 25 or 26, which is information about at least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184.
  • the memory unit further memorizes preventive measures according to the resistance of the skin to aging.
  • the processing unit reads out the preventive measures according to the resistance determined in the processing unit from the storage unit.
  • the determination device according to any one of items 24 to 27, wherein the output unit outputs the read preventive action.
  • the processing unit of the determination device has cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization. 28. Item 28, wherein a plurality of resistances selected from the group consisting of forces are determined, and the output unit of the determination device outputs a corresponding preventive measure for at least one resistance determined to have low resistance. Determination device.
  • a program that causes a computer including an input unit, a storage unit, a processing unit, and an output unit to determine the resistance to skin aging and is described as follows:
  • the processing unit is made to compare the SNP information about the genes involved in the resistance to skin aging input from the input unit with the relationship between the SNP information previously stored in the storage unit and the resistance to skin aging.
  • a command that determines the resistance of the skin to aging The program comprising a command to output the determined resistance to skin aging from the output unit.
  • the resistance to aging of the skin is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization.
  • the gene involved in cell active force is at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
  • the gene involved in the skin shielding force is at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
  • the gene involved in face shape modeling ability is at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1.
  • the gene involved in metabolic maintenance is at least one gene selected from the group consisting of VEGFA and VEGFC.
  • the gene involved in skin color assisting power is at least one gene selected from the group consisting of OCA2 and IRF4.
  • the gene involved in stimulus protection is at least one gene selected from the group consisting of SOD2 and GPX1.
  • the gene involved in damage control is at least one gene selected from the group consisting of TNF- ⁇ , PLAU (uPA), and TNFR2.
  • the gene involved in aquavitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood.
  • the program according to item 31, wherein the gene involved in the ability to utilize oil vitamins is at least one gene selected from the group consisting of genes related to the control of vitamin A level, vitamin D level, and vitamin E level in blood. ..
  • SNP information about genes involved in cell active force is as follows: Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
  • SNP information about genes involved in skin shielding is as follows: Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
  • SNP information about genes involved in face shape modeling ability is as follows: rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Information about at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509.
  • SNP information about genes involved in metabolic maintenance is as follows: Information about at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061.
  • SNP information about genes involved in skin color assisting power is as follows: At least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071.
  • Information about SNP information about genes involved in stimulus protection is as follows: Information about at least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164.
  • SNP information about genes involved in damage control is as follows: Information about at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673.
  • SNP information on genes involved in aquavitamin utilization is as follows: Information about at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
  • SNP information on genes involved in oil-vitamin utilization is as follows: The program according to item 31 or 32, which is information about at least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184. ..
  • the program is as follows: A command to memorize preventive measures according to the resistance of the skin to aging in the memory unit, A command to operate the processing unit to read the preventive action according to the resistance determined in the processing unit from the storage unit, The program according to any one of items 30 to 33, further comprising a command to output the read action to the output unit.
  • the program consists of a computer with cell activation power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power.
  • the program of item 34 comprising a command to output a corresponding preventive action for at least one resistance determined by the processing unit to be low resistance.
  • FIG. 1A is a diagram schematically showing an information processing apparatus including an input unit, a storage unit, a processing unit, and an output unit.
  • FIG. 1B is a diagram schematically showing a system in which an information processing apparatus operates via a network.
  • 2A to 2B are schematic views showing a flow for the information processing apparatus of the present invention to determine the resistance to aging of the skin according to a program.
  • 2C to 2D are schematic views showing a flow for the information processing apparatus of the present invention to determine the resistance to aging of the skin according to a program.
  • FIG. 3 shows a graph in which objects belonging to a certain ratio of the high price side and the low price side are classified into a high price group and a low price group from the measured values of the skin condition (wrinkles).
  • FIG. 4 is a graph of the ROC curve showing the relationship between sensitivity and specificity, which was created when the learning model for determining the skin constitution was verified.
  • the present invention relates to a method for determining the resistance of a skin to aging based on the SNP information of a subject.
  • SNP information of the subject information about one or more SNPs in the gene involved in the resistance of the skin to aging can be used.
  • the skin condition changes with aging, and the degree of skin aging is affected by the genetic background.
  • spots, wrinkles, skin elasticity, melanin amount, skin brightness, yellowing, upper arm skin color, etc. change with aging.
  • the resistance of the skin to aging refers to the ability to delay the progression of aging and depends on the genetic background. That is, the progress of aging is affected by the accumulation of changes caused in the living body in daily life represented by aging, and also by external environmental factors such as ultraviolet rays and dryness. The resistance to such internal and external effects of promoting skin aging varies from individual to individual due to their genetic background.
  • knowing the resistance of the skin to aging based on the genetic background means knowing the resistance to the effects of acquired internal and external skin aging-promoting factors. Since the internal and external skin aging-promoting factors have a wide range of effects on the skin, the skin aging resistance that affects the responsiveness of the skin is set and added to each individual to prevent individual skin aging. Resistance is determined.
  • the resistance to skin aging determined based on the SNP information of the subject refers to the resistance to skin aging based on the genetic background.
  • Acquired factors that affect skin aging include internal lifestyle habits such as stress and nutritional status such as disordered eating habits, and external factors such as ultraviolet rays and dryness.
  • internal lifestyle habits such as stress and nutritional status such as disordered eating habits
  • external factors such as ultraviolet rays and dryness.
  • the resistance to aging of the skin evaluated by the genetic background is low, it is possible to delay the aging of the skin by changing the acquired environmental factors, that is, the lifestyle and the external environment. Lifestyles involved in skin aging include eating habits, sleep rhythms, excessive exercise, or lack of exercise.
  • Examples of the external environment involved in skin aging include ultraviolet rays, pollutants, gravity, and changes in the temperature and humidity of living spaces.
  • the SNP involved in determining the resistance to skin aging is a skin aging model set by machine learning the relationship between the genetic information and environmental information regarding the subject's SNP and the measurement data of the skin condition.
  • the SNP adopted in the formula is used. From the SNP adopted in the skin aging model formula, genes involved in skin function are clarified by dermatological research, genes involved in aging resistance are selected, and groups are grouped by function. SNPs that affect the function of genes selected through this selection process can exhibit resistance to skin aging with respect to grouped functions.
  • the SNP used in the present invention includes the following: rs1050565, rs8110862, rs2232228, rs2227564, rs1799750, rs7201, rs17577, rs8326, rs2046571, rs2246416, rs1107946, rs2010963, rs1485766, rs1800414, rs1540771, rs4880, rs1050450, rs1799724, rs1061622, rs1801133 rs2158467, rs3785079, rs4065, rs5854, rs2241145, rs9509, rs2071307, rs1057308, rs7149187, rs1057297, rs833061, rs475106, rs74653330, rs12203592, rs7855, rs3448
  • the resistance to skin aging in the present invention is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aquavitamin. At least one resistance selected from the group consisting of utilization ability and oil vitamin utilization ability.
  • Cell active power can be said to be moisturizing power, anti-aging moisturizing power, cell homeostasis power, cell environment maintenance power, cell metabolism regulation power, skin metabolism power, and skin moisturizing power, and properly maintains the water content of the skin stratum corneum. It is a power to enhance work. .. By properly maintaining the water content of the skin stratum corneum, the action of enzymes in the stratum corneum is maintained, and skin metabolism and homeostasis are maintained. Moisture in the stratum corneum also contributes to the softness of the skin and alleviates the effects of facial expression on the shape of the skin surface.
  • Moisture in the stratum corneum which is so important, can be increased by increasing the production of natural moisturizing factors (NMFs), thereby normalizing epidermal differentiation and enhancing barrier function.
  • NMFs moisturizing factors
  • Examples of genes involved in cell active force include bleomycin hydrolase (BLMH), caspase 14 (CASP14), and hyaluronan synthase 3 (HAS3).
  • the SNP related to cell active force at least one selected from the group consisting of the following: rs1050565, rs1552472, rs2129785, rs3103308, rs3190884, rs8110862, rs2158467, rs3181162, rs717309, rs2158467, rs2232228, rs3785079, rs2232227, rs3759981, rs3785079 is used. Can be done. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine the resistance of the skin to aging due to moisturizing power. The relationship between each SNP and the gene is shown in the table below.
  • the skin shielding power can also be said to be barrier power, anti-aging barrier defense power, skin wrapping power, skin internal stabilization power, skin gate power, and skin gate keeping power to prevent skin moisture from leaking to the outside. , It is the power to keep the barrier function good so that substances that have an adverse effect from the outside cannot easily enter.
  • the barrier function is maintained well. Examples of genes involved in skin shielding power include urokinase-type plasminogen activator (uPA) and caspase 14 (CASP14).
  • the SNP related to the skin shielding force at least one selected from the group consisting of the following: rs2227564, rs4065, rs2227566, rs2227568, rs2227574, rs8110862, rs2158467, rs3181162, rs717309, rs2158467 can be used.
  • any combination of such SNPs, and optionally all combinations, can be used to determine the resistance of the skin to aging with respect to barrier function. The relationship between each SNP and the gene is shown in the table below.
  • the facial shape modeling force can also be referred to as skin internal structural force, face shape-up force, firmness-up force, and skin foaming force, and its constituent elements are anti-aging dermis epidermis cooperation force and anti-aging dermis elastic assisting force.
  • the anti-aging dermis epidermis cooperation ability can be said to be the ability to keep the skin layer and the ability to communicate with the skin, and refers to the ability to maintain the basement membrane at the boundary between the epidermis and the dermis and improve the function of the skin.
  • the anti-aging dermis elastic assist force can be said to be a skin spring adjusting force and a skin spring force, and is a force for maintaining the dermis structure that maintains the elasticity of the skin.
  • Matrix metalloproteinase-1 MMP-1
  • matrix metalloproteinase-2 MMP-2
  • matrix metalloproteinase-9 MMP-9
  • elastin ENN
  • hyaluronan synthase as genes involved in facial shape modeling ability
  • Examples include enzyme 2 (HAS2), fibrin 5 (FBRN5), and type I collagen (COL1A1).
  • SNPs related to face shape modeling ability include: rs1799750, rs5854, rs470558, rs1144391, rs17884110, rs7201, rs2241145, rs1030868, rs2285053, rs2287074, rs17577, rs9509, rs13925, rs13969, rs17576, rs8326, rs2071307, rs2856728, rs.
  • At least one selected from the group consisting of rs17855988, rs2046571, rs1057308, rs1871884, rs4255143, rs4618701, rs2246416, rs7149187, rs2430347, rs17804735, rs77357345, rs1107946, rs1057297, rs1061237, rs1061947, rs1800012 can be used.
  • any combination of such SNPs, and optionally all combinations can be used to determine resistance to aging due to anti-aging dermal epidermal coordination and anti-aging dermal elastic assisting forces. The relationship between each SNP and the gene is shown in the table below.
  • Metabolism maintenance power can also be said to be circulation power, anti-aging circulation regulation power, circulation support power, circulation maintenance power, holistic cooperation power, skin nutrition supply power, and lymph that removes blood vessels and waste products that supplement nutrition. It is the power to improve.
  • genes involved in metabolic maintenance include vascular endothelial growth factor A (VEGFA) and vascular endothelial growth factor C (VEGFC).
  • VAGFA vascular endothelial growth factor A
  • VAGFC vascular endothelial growth factor C
  • SNP involved in metabolic maintenance at least one selected from the group consisting of the following: rs2010963, rs833061, rs699947, rs10434, rs735286, rs1485766, rs475106, rs475106, rs475920, rs510684 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging caused by blood vessels and lymph.
  • Skin color assist power can also be said to be skin color adjustment power, anti-aging skin color adjustment power, UV filter power, skin color maintenance power, UV response power, photoaging response power, and high melanin, which has a natural UV protection function in the skin. It is the power to keep.
  • Genes involved in skin color assisting power include oculocutaneous albinism type II (OCA2) and interferon regulator (IRF4).
  • the SNP related to the skin color assisting power at least one selected from the group consisting of the following: rs1800414, rs74653330, rs12913832, rs1800404, rs1800411, rs1540771, rs12203592, rs872071, rs1050975, rs1131442 can be used.
  • any combination of such SNPs, and optionally all combinations, can be used to determine resistance to melanin-induced aging. The relationship between each SNP and the gene is shown in the table below.
  • the stimulus protection power can also be said to be antioxidant power, anti-aging oxidative power, stimulus scavenging power, stimulus sedative power, damage blocking power, and damage absorbing power, and is the power to detoxify and remove active oxygen generated in the skin.
  • Reactive oxygen species are removed intracellularly by the action of enzymes such as superoxide dismutase and glutathione peroxidase. Examples of genes involved in stimulus protection include superoxide dismutase-2 (SOD2) and glutathione peroxidase 1 (GPX1).
  • the SNP related to the stimulus protection power at least one selected from the group consisting of the following: rs4880, rs7855, rs8031, rs10370, rs732498, rs1050450, rs3448, rs1800668, rs3811699, rs8179164 can be used.
  • any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging due to anti-aging oxidative power. The relationship between each SNP and the gene is shown in the table below.
  • the damage control power can also be said to be inflammation control power, anti-aging anti-inflammatory power, inflammation control power, skin internal calming power, damage fire extinguishing power, and skin attack control power, and reduces or suppresses the production of inflammatory factors in the skin. It is power. Inflammation can be suppressed by reducing inflammatory factors.
  • Genes involved in damage control ability include tumor necrosis factor ⁇ (TNF ⁇ ), urokinase-type plasminogen activator (PLAU (uPA)), and tumor necrosis factor receptor 2 (TNFR2).
  • the ability to utilize aqua vitamins can be said to be anti-aging water-soluble vitamin control ability, aqua vitamin optimization ability, and aqua vitamin adjustment ability, and is the ability to normalize the blood concentration of water-soluble vitamins.
  • Genes involved in aquavitamin utilization include genes that affect the control of blood levels of vitamin B2 and vitamin B12.
  • SNP related to the aquavitamin utilization ability at least one selected from the group consisting of the following: rs1801133, rs2298585, rs1047781, rs3760776, rs10515552, rs3760776 can be used.
  • any combination of such SNPs, and optionally all combinations can be used to determine resistance to aging due to aquavitamin blood levels. The relationship between each SNP and the gene is shown in the table below.
  • the ability to utilize oil vitamins can be said to be anti-aging oil-soluble vitamin control ability, oil vitamin optimization ability, and oil vitamin adjustment ability, and is the ability to normalize the blood concentration of fat-soluble vitamins.
  • Genes involved in the ability to utilize oil vitamins include genes that affect the control of blood levels of vitamin A, vitamin D, and vitamin E.
  • the SNP related to the ability to utilize oils and vitamins at least one selected from the group consisting of the following: rs10882272, rs1667255, rs12934922, rs7501331, rs2282679, rs11234027, rs12785878, rs1993116, rs2060793, rs2108622, rs964184, rs11057830, rs12272004 can be used.
  • any combination of such SNPs, and optionally all combinations can be used to determine resistance to aging due to oil vitamin blood levels. The relationship between each SNP and the gene is shown in the table below.
  • Input section for inputting SNP information A storage unit that stores the relationship between SNP information and the resistance of the skin to aging in advance.
  • a processing unit that determines the resistance to skin aging by comparing the SNP information input from the input unit with the relationship between the SNP information stored in advance in the storage unit and the resistance to skin aging, and the determined unit. It relates to a device for determining the resistance to skin aging, including an output unit that outputs the resistance to skin aging.
  • the SNP information used in the determination device of the present invention may be the same as the SNP information used in the method of the present invention.
  • the invention is a program that causes a computer to determine resistance to skin aging, including: input, storage, processing, and output: A command to have the processing unit compare the relationship between the SNP information input from the input unit, the SNP information stored in the storage unit in advance, and the resistance to skin aging, and determine the resistance to skin aging; It also relates to a program that includes a command to output the determined resistance to skin aging from the output section.
  • the SNP information used in the program of the present invention may be the same as the SNP information used in the method of the present invention.
  • the genotype (major homotype: Homo1, heterotype: Hetero,) was selected for each SNP for each resistance to aging.
  • Minor homozygotes Scores can be determined based on Homo2).
  • the table below shows the correspondence between major homozygotes (Homo1), phenotypes, and genetic models of each gene in SNP.
  • the SNP of a certain gene When the SNP of a certain gene is a major homozygous and increases resistance, it is described as Homo1: high, and when it decreases resistance, it is described as Homo1: low.
  • Homo1 high, and when it decreases resistance, it is described as Homo1: low.
  • four genetic models Dominant, Recessive, Additive, Multiplicative selected for each SNP using the skin constitution results among the analysis results obtained in the relationship study between skin quality and gene SNP (Dominant, Recessive, Additive, Multiplicative) Calculate the frequency of and adopt the model that appears most frequently.
  • the score can be arbitrarily determined according to the strength of the resistance in each model. As an example, for SNPs whose resistance is reduced in the major homozygous type, the resistance in each genetic model is expressed as shown in the table below and scored respectively.
  • the method, determination device, and / or program of the present invention has cell active power, skin shielding power, face shape modeling power, metabolic maintenance power, skin color assisting power, stimulus protection power, damage control power, aquavitamin utilization power, and oil. It is possible to determine the resistance to aging of at least one skin selected from the group consisting of vitamin utilization.
  • the method, determination device, and / or program of the present invention can determine the resistance to a plurality of skin aging among the above-mentioned resistance to skin aging. More preferably, it determines the resistance of 2, 3, 4, 5, 6, 7, 8 or 9 to skin aging. Prophylactic measures against aging can be provided depending on the resistance to aging determined by the methods, determination devices, and / or programs of the present invention.
  • the one having the lowest score for resistance to aging can be selected in order to provide preventive measures. If the scores are equivalent, the resistance to aging to be selected can be determined based on the results of a separately obtained questionnaire. Since the resistance to aging displayed in this way is genetically weak resistance, it is necessary to take priority measures.
  • the SNP is represented by an rs number (Reference SNP ID number).
  • rs number Reference SNP ID number
  • Detailed information on SNPs (positions and mutations on chromosomes) corresponding to each rs number is managed by the National Center for Biotechnology Information (NCBI), and is managed by the NCBI homepage ( http://www.ncbi.nlm.). It can be referred to in nih.gov /).
  • SNP detection may be performed by any known method.
  • a subject's nucleic acid is purified from a subject's biological sample such as saliva, blood, mucous membrane, tissue piece, hair, etc. according to a conventional method, and SNP is detected in the purified nucleic acid. Therefore, the method for determining skin characteristics of the present invention may further include a sample preparation step and a nucleic acid purification step.
  • the nucleic acid may be DNA or RNA, and in the case of RNA, it is preferable to perform reverse transcription after purification to prepare DNA.
  • any method can be used as long as it is a method that enables detection of SNP in purified nucleic acid.
  • SNPs can be detected by sequencing around the position of the target SNP, or by using a PCR-based method, a DNA probe method, or a mass spectrometry method. You can also.
  • PCR-based methods include SNP typing method, TaqMan PCR method, single nucleotide extension method, Pyrosequencing method, and Exonuclease Cycling Assay method.
  • the method using a DNA probe include a DNA chip method (DNA microarray) and an Invader method (Comprehensive Gene Polymorphism Analysis (SNP) Nikkei Journal, 125, 148-152, 2005).
  • An SNP may be accompanied by another SNP that is in linkage disequilibrium.
  • the target SNP can be detected by detecting the SNP that is in linkage disequilibrium with the target SNP. Therefore, in the present invention, the detection of SNP is not limited to directly detecting the target SNP, but also includes detecting the target SNP by detecting the SNP in linkage disequilibrium. And.
  • the presence of the SNP can be detected by examining the sequence at the position where the SNP exists in the data of the base sequence already determined. Therefore, the detection of the SNP in this case may be performed by inputting the base sequence data to the computer in which the SNP information is stored.
  • the input is input from the terminal via the Internet
  • the SNP is detected on the server
  • the detection result can be output to the terminal via the Internet.
  • FIG. 1A shows a specific configuration of a determination device of the present invention including an input unit 11, a storage unit 12, a processing unit 13, and an output unit 14.
  • the determination device of the present invention may be the information processing device 10 or may form a system 20 connected to the information processing device 10 via a network (FIG. 1B).
  • a terminal 30 exists separately from the information processing device 10, and is connected to the information processing device 10 via a network.
  • the connection between the terminal 30 and the information processing device 10 may be wired or wireless. As an example, it may be connected via an intranet or the Internet.
  • the input unit 11 further includes an interface for any device that enables data input. It may be connected to an external storage device such as a keyboard, an operation unit such as a mouse, a communication unit, a CD-ROM, a DVD-ROM, a BD-ROM, or a memory stick via an interface. Information is input to the information processing device via the input unit 11.
  • the information input from the input unit may include a command or the like in addition to the SNP information.
  • Information about the SNP may be input from the input unit 11 and stored in the storage unit 12.
  • the genetic sequence information of the target may be input from the input unit 11.
  • the input sequence information may be temporarily stored in the storage unit 12 or may be sent to the processing unit 13 as it is.
  • the genetic sequence information of the target may be the whole genome sequence of the target, only a partial sequence of interest, or only SNP information. Processing instructions in the processing unit 13 can be given from the input unit 11 via the operation unit.
  • the storage unit 12 includes, for example, a memory device such as a RAM, ROM, or a flash memory, a fixed disk device such as a hard disk drive, or a portable storage device such as a flexible disk or an optical disk, with respect to any device for storing data. ..
  • the storage unit 12 stores data and instructions input from the input unit 11, programs used for various processing of the computer, processing results by the processing unit 13, a database, a form to be output to the output unit 14, and the like.
  • the computer program may be installed via a computer-readable recording medium such as a CD-ROM or a DVD-ROM, or via the Internet.
  • the computer program is installed in the storage unit 12 using a known setup program or the like.
  • the storage unit 12 stores the relationship between the SNP information and the resistance of the skin to aging. In addition, a table or mathematical formula for scoring the resistance of the skin to aging is stored. The relationship with preventive measures against skin aging resistance according to the score may also be remembered. In addition, the storage unit 12 may store information about the results of a questionnaire regarding skin problems.
  • the processing unit 13 is an arbitrary device that performs arithmetic processing, and usually has one or a plurality of processors or peripheral circuits thereof.
  • the processing unit 13 comprehensively controls the overall operation of the information processing device 10, and is, for example, a central processing unit (CPU).
  • the processing unit 13 executes various arithmetic processes according to the program stored in the storage unit 12.
  • the arithmetic processing is performed by the processor included in the processing unit 13.
  • This processor includes a functional module that controls an input unit 11, a storage unit 12, and an output unit 14, and can perform various controls. Each of these parts may be composed of independent integrated circuits, microprocessors, firmware, and the like.
  • the processing unit 13 reads out the relationship between the SNP information input from the input unit 11 and the SNP information stored in the storage unit 12 and the resistance to skin aging, and determines the resistance to skin aging.
  • the resistance may be determined by reading out and scoring a table or mathematical formula for scoring the resistance of the skin to aging stored in the storage unit 12. Score the resistance to aging of multiple skins and take preventive measures for the resistance to aging of a given number of, eg, 1, 2, 3, or 4, preferably 3 low-scoring skins. It can be read from and determined. When the scores are the same, the processing unit 13 further reads out the results of the separately acquired questionnaire for skin problems from the storage unit 12, and determines which one should be selected for the resistance to aging of the skin having the same score.
  • the processing unit 13 can also operate to detect the presence of the SNP in the genetic sequence information when the target genetic sequence information is input instead of the SNP information. More specifically, the processing unit 13 detects the presence of the SNP in the target sequence information from the sequence information of the SNP stored in advance in the storage unit 12 and the target sequence information input from the input unit 11. be able to. Information about the existence of the SNP detected by the processing unit 13 may be temporarily stored in the storage unit 12.
  • the output unit 14 is an arbitrary device capable of outputting the processing result by the processing unit 13, for example, a display device such as a liquid crystal display that directly displays the result, an output means such as a printer, and may include an interface. It may be connected to a communication unit or an external storage device for output via a network via an interface.
  • the communication unit used in the input unit 11 and the output unit 14 relates to a communication interface such as a LAN or a port for connecting an information processing device to a network.
  • the output unit 14 outputs, for example, the resistance to aging of the skin of the subject as a result of the processing by the processing unit 13. Further, the output unit 14 outputs SNP information possessed by the subject and preventive measures for those having low resistance to skin aging.
  • Steping can be performed based on the resistance of the skin to aging output from the output unit 14.
  • preventive and strengthening measures can be provided according to the resistance of the skin to aging. "Depending on the resistance of the skin to aging” is to provide a treatment that can supplement the resistance when the resistance is low.
  • the relationship between the resistance to skin aging and the preventive measures may be stored in the storage unit 12 in advance, and the output unit 14 outputs the information on the preventive measures together with the output of the resistance to the skin aging. be able to.
  • the preventive treatment in addition to cosmetic treatments such as the frequency and method of use of cosmetics and ingredients, treatments that change lifestyle habits and the external environment may be used.
  • preventive measures can be proposed not only for cosmetics and other cosmetic treatments that are directly applied to the skin and how to use them, but also for behaviors such as food, sleep, exercise, bathing, and mental activity.
  • treatments to increase cell activity can be proposed.
  • treatments include cosmetological treatments such as facial masks and beauty treatments, products that enhance water retention, use of humidifiers, exercise to improve blood circulation, and meditation that is effective for moisturizing.
  • treatments to enhance skin shielding power can be proposed.
  • Such measures include measures to reduce stress such as aroma, products for reviewing sleep time and recovery from fatigue, diets rich in ⁇ 3 oil and minerals, and intestinal activity.
  • measures to reduce stress such as aroma
  • products for reviewing sleep time and recovery from fatigue diets rich in ⁇ 3 oil and minerals, and intestinal activity.
  • Such procedures include facial muscle exercises such as massage and face yoga, drinking collagen drinks, protein-rich diets, and the use of products that avoid blue light.
  • treatments to enhance metabolic maintenance ability can be proposed.
  • Such treatments include cosmetological measures that promote blood circulation and improve lymphatic flow, exercise such as hot yoga and kaatsu training, ginger that promotes blood circulation, a diet rich in vitamins A and E, and sleeping methods that suppress swelling. Can be mentioned.
  • Such measures include the use of sunscreen goods such as sunscreens and parasols, meals containing a large amount of green-yellow vegetables and nuts to prevent photoaging, and indoor sun bathing in the morning to adjust the rhythm.
  • sunscreen goods such as sunscreens and parasols
  • meals containing a large amount of green-yellow vegetables and nuts to prevent photoaging, and indoor sun bathing in the morning to adjust the rhythm.
  • treatments to enhance stimulus protection can be proposed.
  • examples of such treatment include cosmetics having an antioxidant effect, a diet rich in polyphenols and vitamin C, slow jog that enhances the defense power of the whole body, and bathing in lukewarm water.
  • measures to enhance damage control power For subjects who are evaluated as having weak damage control power.
  • Such treatments include the use of anti-inflammatory cosmetics, products containing turmeric, a nutritionally balanced diet, and 10-minute exercises to prevent systemic muscle weakness.
  • treatments to enhance aquavitamin utilization can be proposed.
  • Such treatments include cosmetics and supplements containing vitamin derivatives, pork dishes, how to prepare and monitor autonomic nerves, and effective vitamin intake methods after exercise.
  • treatments to enhance oil-vitamin utilization can be proposed.
  • Such treatments include ⁇ -carotene supplements and fruits, diets that utilize fish and mushrooms, proper sunbathing methods, and suggestions for goods that avoid pollinosis and air pollution.
  • Example 1 Analysis target Female volunteers (1448) aged 20 to 79 years were targeted. Prior to the analysis, a questionnaire survey was conducted on age, height, weight, BMI (calculated from height and weight according to a standard method), UV exposure information, and smoking information. Regarding exposure information to UV rays, the current tanning consciousness is classified into 4 stages (2 stages of sunburn-oriented, 2 stages of non-tanning-oriented), and in order to grasp the response to UV rays in detail, from birth to the present ( 3 levels of sunburn measures (1-14 years old, 15-19 years old, 20-24 years old, 25-29 years old, and beyond in 10-year increments) (actively without UV protection, UV protection against strong sunlight) , Weak sunlight was also classified by UV protection) and the survey was conducted. The survey was divided into three groups: no smoking history, 20 or more cigarettes per day in the past, and less than 20 cigarettes per day in the past.
  • Example 2 Acquisition of actual skin measurement data in the analysis target As skin characteristic values, wrinkles, stains, and skin colors (cheek melanin amount, brightness, yellowness, inside upper arm) of female volunteers aged 20 to 79 years were targeted. Skin color) and elasticity were measured. For each measurement, using Visia Evolution (manufactured by Canfield Scientific) for the wrinkle state and the spot state, the index value of wrinkles and spots (spot 1) is calculated from the captured image by a dedicated analysis method, and the spot is the skin. The number of stains (stain 2) and the area of stains (stain 3) by the image measuring device were also calculated and used for the analysis.
  • Visia Evolution manufactured by Canfield Scientific
  • the skin color was analyzed using a spectrophotometer CM-700d (Konica Minolta), and the amount of melanin in the cheeks (skin color 1), brightness (L * / color measurement value) (skin color 2), and yellowness (b *). -Measurement value) (skin color 3) was measured, and the inner skin color of the upper arm (skin color 4) was also measured.
  • the elasticity was measured using a dedicated commercially available device (Cutometer). For wrinkles on the eyes, a replica of the skin surface is made from silicon, three-dimensionally measured, the data is taken into a computer, and image processing is performed using a unique analysis system to calculate the maximum depth, volume, and area of the wrinkles. bottom.
  • Example 3 Determination of SNP in the analysis target The following 79 types of SNPs that are expected to affect the skin characteristic values were selected from the past dermatological findings. rs1800629, rs2108622, rs1047781, rs12203592, rs16891982, rs3760776, rs9340799, rs12913832, rs17822931, rs964184, rs1801133, rs2228479, rs10515552, rs10741657, rs10882272, rs11057830, rs11234027, rs12272004, rs12377462 rs2227564, rs2282679, rs2298585, rs3829251, rs41281112, rs4654748, rs492602, rs602662, rs1030868, rs1126643, rs1256062, r
  • the selection criteria were epidermis, basement membrane, dermis, panniculus adipos, factors that function in the whole body (hormones, vitamins, etc.), enzymes, extracellular matrix proteins, etc., and genes with SNP were selected as candidates. .. It is possible that these SNPs affect various skin traits.
  • 4 types of genetic models consisting of a recessive model, a dominant model, an additive model, and a synergistic model are set, and for 79 types of SNPs, a total of 316 types of genetic models are considered. Was used as genetic information.
  • the optimal genetic model for each SNP was determined.
  • the genetic model prior to the creation of the learning model according to the present invention it is expected that the accuracy of determining the skin constitution by SNP will be improved.
  • Saliva was used as a sample in determining the SNP in the analysis target. Saliva was collected using Oragene® DNA OG-500 (DNA Genotek Inc.) to stabilize the DNA. DNA was purified from saliva, SNPs were determined using a DNA array, and information on the above 79 types of SNPs selected in advance was obtained.
  • Example 4 Creation of a learning model for classifying into a high-value group and a non-high-value group (or a low-value group and a non-low-value group) and determining the skin constitution using the classification result as an objective variable Wrinkles and stains (stains 1 to 3) ), Cheek melanin amount (skin color 1), brightness (skin color 2), yellowness (skin color 3), upper arm inner skin color (skin color 4), elasticity, wrinkle area, wrinkle volume, wrinkle maximum depth Based on the measured values of the skin condition, the high value group and the low value group of the skin condition were determined for each age group from the distribution of the respective measured values.
  • the measured value of the skin obtained by the skin inspection Is defined as 1 when it is the top 25% of all data included in each age group (range of 5 years division of age), and 0 when it is not (non-high value group) (Fig. 3).
  • the measured values of the skin obtained by the skin test are each. The case where it is the lower 25% of all the data included in the age (range of 5 years division of age) is defined as 1, and the other cases are defined as 0.
  • the high price group is set to 1 and the non-high price group is set to 0, and information on 79 types of SNPs and information on environmental factors based on the questionnaire results are input as explanatory variables, and logistic regression analysis is performed.
  • n 1 to 4 (m1) and 5 to 10 (m2), respectively.
  • a constant term is determined for each explanatory variable, and by inputting the explanatory variable, the tendency of the skin constitution to become the objective variable (possibility of belonging to the high value group of the skin condition) and / Or it is possible to output the difficulty of skin constitution (possibility of belonging to the low value group of skin condition).
  • Example 5 Verification of learning model For the created learning model for determining the skin constitution, the ease (or difficulty) of the skin constitution output by inputting the explanatory variables of the verification data and the verification. Based on the classification of the data into the high value group (or low value group) of the skin condition, the ROC curve was obtained, and the area under the ROC curve (AUC) and the sensitivity (Sensitivity) were obtained (FIG. 4). Sensitivity is a value set regardless of the optimum cutoff value obtained from the ROC curve (value at the point where the distance from the upper left corner of the ROC curve (point where both sensitivity and specificity are 1) is the minimum, etc.) and the ROC curve.
  • the cutoff value is set to 0.5, etc.
  • the appearance frequency of SNP is investigated, and each skin constitution (stain 1, stain 2, stain 3, skin color 1, skin color 2, skin color 3, skin color 4, wrinkles.
  • the table below shows the SNPs used in the learning model for determining elasticity, wrinkle area, wrinkle volume, and maximum wrinkle depth. Based on the frequency of appearance of SNPs and biochemical knowledge, the SNPs used for the learning model were selected, and from the created learning models, a learning model with a high AUC was selected while using the SNPs.
  • SNPs listed above are the SNPs used in the aging model formula for each skin condition, respectively.
  • the functional aspects of the genes to which these SNPs belong were examined, and the genes involved in skin aging resistance were confirmed. Then, SNPs that affect the function of each gene were investigated, selected, and shown in the table.
  • Example 6 Evaluation of skin aging resistance Obtaining SNP information acquired from a subject, cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, Scores were calculated for each of the aqua vitamin utilization ability and the oil vitamin utilization ability based on the phenotype and genetic model of each SNP. Specifically, scores were given for each SNP phenotype according to the table below. Three resistances with low scores were selected, and the three resistances recommended for the subject to prevent and strengthen the resistance. Preventive measures against aging can be proposed for the three low-scoring resistances.
  • Example 7 Verification of evaluated skin resistance Three types of skin aging resistance that we recommend customers to prevent and strengthen by clarifying the strength and balance of nine types of skin resistance to aging from the results of genetic tests. We have developed an algorithm to propose power. The effectiveness of this algorithm was verified based on the genetic test results, skin measurement results, and skin trouble questionnaire results of the subjects (about 1500 persons). Specifically, for the SNPs possessed by the subjects, the resistance of each skin of the subjects to aging was scored according to the definitions in Tables 25 and 26. In addition, when the three powers cannot be defined only by the genetic test results, we succeeded in narrowing down the resistance to skin aging by using the results of nine kinds of skin trouble questionnaires originally created by the present inventors.
  • this algorithm newly developed by the present inventors supports the improvement of the balance of resistance to skin aging according to the customer's personalized skin constitution and skin troubles, and is the core of the service newly developed by us. It shows that it is appropriate as a technology.
  • Example 8 Example showing the effectiveness of the method for determining the resistance to skin aging of the present invention
  • the daily intake of water-soluble vitamins is shown in Table 27.
  • Table 28 shows the degree of stains on both sides. Subjects with higher intake of water-soluble vitamins have less stains. This shows the effectiveness of the method for determining the resistance of the present invention, and is an example in which the influence of skin aging due to SNP is reduced by living according to the resistance.

Abstract

The purpose of the present invention is to provide a skin test based on SNP analysis, the results of said test being satisfactory for subjects and motivating behavior changes. Provided is a method that comprises evaluating the results of SNP analysis from the viewpoint of resistance against skin aging.

Description

遺伝子多型を用いた肌の老化に対する抵抗力の決定方法Method for determining resistance to skin aging using gene polymorphisms
 本発明は、遺伝子検査に基づく、肌の老化に対する抵抗力の決定方法、肌の老化に対する抵抗力の評価システム、及び、肌の老化に対する抵抗力の評価システムの制御プログラムに関する。本発明の肌の老化に対する抵抗力の決定方法、システム、及びプログラムに基づき、肌カウンセリングが可能となる。 The present invention relates to a method for determining resistance to skin aging based on a genetic test, a control program for an evaluation system for skin aging resistance, and a control program for a skin aging resistance evaluation system. Skin counseling is possible based on the method, system, and program for determining the resistance of the skin to aging of the present invention.
 近年、遺伝子のSNP解析に基づく肌検査が提案されており、特に肌質に直接関与するタンパク質をコードする遺伝子について、SNP情報と肌質との関連性が研究されている。その結果、SNP解析結果に基づき、肌特性や、肌トラブルを予測する方法が提供されてきている。これらの研究では、肌質、例えばシワ、シミに直接関わることが明らかになっている遺伝子を対象として、SNPが調べられている。このような対象の遺伝子としては、例えば、MC1R、MMP1、SOD2、GPX1、ASIPなどが標的とされている。一方で、皮膚の肌特性に影響を与える遺伝子は、多岐に渡ることから、より多くの遺伝子におけるSNP情報と肌特性との関係についても調べられている(特許文献1:国際公開第2018/101449号)。 In recent years, skin tests based on SNP analysis of genes have been proposed, and the relationship between SNP information and skin quality is being studied, especially for genes encoding proteins that are directly involved in skin quality. As a result, a method for predicting skin characteristics and skin troubles based on the SNP analysis result has been provided. In these studies, SNPs are being investigated for genes that have been shown to be directly involved in skin quality, such as wrinkles and age spots. As such a target gene, for example, MC1R, MMP1, SOD2, GPX1, SIP and the like are targeted. On the other hand, since there are a wide variety of genes that affect the skin characteristics of the skin, the relationship between SNP information and skin characteristics in more genes has also been investigated (Patent Document 1: International Publication No. 2018/101449). issue).
国際公開第2018/101449号International Publication No. 2018/101449
 SNP解析に基づく肌検査は、被験者のSNPに関する遺伝情報と、肌状態の測定データとの間の統計学的手法に基づいて行われている。被験者のSNP情報に基づいて決定された肌質は統計学的手法に用いた肌状態の測定データに対応しているが、被験者が感じている肌状態についての評価との乖離が生じることが問題となっている。その理由としては、肌状態は遺伝的背景のみならず、後天的な環境要因に応じて変化するものであり、SNP解析に基づく肌質の評価は必ずしも被験者の現在の肌状態を表していないことが挙げられる。また、遺伝子検査の結果は、個人の遺伝的背景を反映しているため、遺伝子検査を受けた被験者は、遺伝子は変えられないものであるという、諦念に至ってしまうという問題がある。 The skin test based on SNP analysis is performed based on a statistical method between the genetic information regarding the subject's SNP and the measurement data of the skin condition. The skin quality determined based on the subject's SNP information corresponds to the skin condition measurement data used in the statistical method, but the problem is that there is a discrepancy with the evaluation of the skin condition felt by the subject. It has become. The reason is that the skin condition changes not only according to the genetic background but also according to the acquired environmental factors, and the evaluation of the skin quality based on the SNP analysis does not necessarily represent the current skin condition of the subject. Can be mentioned. In addition, since the results of the genetic test reflect the genetic background of the individual, there is a problem that the subject who has undergone the genetic test gives up that the gene cannot be changed.
 本発明者らは、かかる課題に対し鋭意研究を行い、SNP解析の結果を、肌状態の評価に用いるのではなく、肌の老化に対する抵抗力という観点で評価する方法を開発するに至った。本発明で選択されたSNPは、遺伝情報と環境情報、及び肌実測データで学習された学習モデルであって、遺伝情報と環境情報を入力した際に、肌体質を出力する学習モデルにより生成された老化モデル式において採用されたSNPである。したがって本発明で選択されたSNPは、肌の老化しやすさへの影響が大きいSNPである。肌が老化しやすいことは老化抵抗力の低さが要因の一つと考えられる。従って本発明で選択されたSNPは肌の老化に対する抵抗力に対して影響が大きいSNPである。このようにして選択されたSNPについての解析の結果である肌の老化に対する抵抗力は、遺伝的背景と対応の取れた評価項目である。本発明で選択されたSNPに基づいた肌の老化に対する抵抗力の評価により、妥当な評価結果が得られるのみならず、低いと評価された抵抗力に対しては、生活習慣などで補うことができる点をアピールすることができる。これにより、消費者の遺伝的要因による諦念を軽減し、SNP解析に新たな価値を提供することができる。肌の老化に対する抵抗力を評価するにあたり、肌の老化を複数の群に分けることで、各群の老化に対する抵抗力をそれぞれ評価することができる。そこで本発明は、下記の発明に関する: The present inventors have conducted diligent research on such a problem, and have come to develop a method for evaluating the result of SNP analysis from the viewpoint of resistance to skin aging, instead of using it for evaluation of skin condition. The SNP selected in the present invention is a learning model learned from genetic information, environmental information, and actual skin measurement data, and is generated by a learning model that outputs the skin constitution when genetic information and environmental information are input. This is the SNP adopted in the aging model formula. Therefore, the SNP selected in the present invention is an SNP having a great influence on the aging susceptibility of the skin. It is considered that one of the factors that the skin is easy to age is the low resistance to aging. Therefore, the SNP selected in the present invention is an SNP having a great influence on the resistance of the skin to aging. The resistance of the skin to aging, which is the result of the analysis of the SNPs selected in this way, is an evaluation item corresponding to the genetic background. By evaluating the resistance to aging of the skin based on the SNP selected in the present invention, not only a reasonable evaluation result can be obtained, but also the resistance evaluated to be low can be supplemented by lifestyle and the like. You can appeal what you can do. This can reduce consumer resignation due to genetic factors and provide new value for SNP analysis. In evaluating the resistance to aging of the skin, by dividing the aging of the skin into a plurality of groups, it is possible to evaluate the resistance to aging of each group. Therefore, the present invention relates to the following invention:
[1] 肌の老化に対する抵抗力に関与する遺伝子におけるSNPに基づく肌の老化に対する抵抗力を決定する方法。
[2] 前記肌の老化が、生活習慣に起因する老化、外部環境に起因する老化、及び加齢に起因する自然老化から選ばれる、項目1に記載の方法。
[3] 前記肌の老化に対する抵抗力が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる少なくとも1である、項目1又は2に記載の方法。
[4] 細胞アクティブ力が、ブレオマイシン水解酵素(BLMH)、カスパーゼ14(CASP14)、及びヒアルロン酸合成酵素3(HAS3)からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
[5] 前記肌の老化に対する抵抗力として、以下の:
rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPにより、細胞アクティブ力に関する肌の老化に対する抵抗力が決定される、項目4に記載の方法。
[6] 肌シールド力が、PLAU(uPA)及びCASP14からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
[7] 前記肌の老化に対する抵抗力として、以下の:
rs2158467、rs2227564、rs2227566、rs2227568、rs2227574、rs3181162、rs4065、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPにより、肌シールド力に関する肌の老化に対する抵抗力が決定される、項目6に記載の方法。
[8] 顔形状モデリング力が、MMP-1、MMP-2、MMP-9、ELN、HAS2、FBLN5、及びCOL1A1からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
[9] 前記肌の老化に対する抵抗力として、rs1799750、rs10233395、rs1030868、rs1057297、rs1057308、rs1061237、rs1061947、rs1107946、rs1144391、rs13925、rs13969、rs17576、rs17577、rs17804735、rs17855988、rs17884110、rs1800012、rs1871884、rs2046571、rs2071307、rs2241145、rs2246416、rs2285053、rs2287074、rs2430347、rs2856728、rs4255143、rs4618701、rs470558、rs5854、rs7149187、rs7201、rs77357345、rs8326、及びrs9509からなる群から選ばれる少なくとも1のSNPにより、顔形状モデリング力に関する肌の老化に対する抵抗力が決定される、項目8に記載の方法。
 [10] 代謝維持力が、VEGFA及びVEGFCからなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
 [11] 前記肌の老化に対する抵抗力として、以下の:
rs1485766、rs10434、rs2010963、rs475106、rs475920、rs510684、rs699947、rs735286、及びrs833061からなる群から選ばれる少なくとも1のSNPにより、代謝維持力に関する肌の老化に対する抵抗力が決定される、項目10に記載の方法。
 [12] 肌色アシスト力が、OCA2及びIRF4からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
 [13] 前記肌の老化に対する抵抗力として、以下の:
rs1800414、rs1050975、rs1131442、rs12203592、rs12913832、rs1540771、rs1800404、rs1800411、rs74653330、及びrs872071からなる群から選ばれる少なくとも1のSNPにより、肌色アシスト力に関する肌の老化に対する抵抗力が決定される、項目12に記載の方法。
 [14] 刺激プロテクト力がSOD2及びGPX1からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
 [15] 前記肌の老化に対する抵抗力として、刺激プロテクト力である場合に、以下の:
rs4880、rs10370、rs1050450、rs1800668、rs3448、rs3811699、rs732498、rs7855、rs8031、及びrs8179164からなる群から選ばれる少なくとも1のSNPにより、刺激プロテクト力に関する肌の老化に対する抵抗力が決定される、項目14に記載の方法。
 [16] ダメージコントロール力がTNF-α、PLAU(uPA)、及びTNFR2からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
[17] 前記肌の老化に対する抵抗力として、以下の:
rs1799724、rs1061622、rs1800629、rs2227564、rs2227566、rs2227568、rs2227574、rs235249、rs3093662、rs3397、rs361525、rs4065、rs472093、rs474247、及びrs673からなる群から選ばれる少なくとも1のSNPにより、ダメージコントロール力に関する肌の老化に対する抵抗力が決定される、項目16に記載の方法。
 [18] アクアビタミン活用力が血液中のビタミンB2 level及びビタミンB12 levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
[19] 前記肌の老化に対する抵抗力として、以下の:
rs1801133、rs1047781、rs10515552、rs2298585、及びrs3760776からなる群から選ばれる少なくとも1のSNPにより、アクアビタミン活用力に関する肌の老化に対する抵抗力が決定される、項目18に記載の方法。
 [20] オイルビタミン活用力が血液中のビタミンA level、ビタミンD level、及びビタミンE levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、項目2又は3に記載の方法。
[21] 前記肌の老化に対する抵抗力として、以下の:
rs10882272、rs11057830、rs11234027、rs12272004、rs12785878、rs12934922、rs1667255、rs1993116、rs2060793、rs2108622、rs2282679、rs7501331、及びrs964184からなる群から選ばれる少なくとも1のSNPにより、オイルビタミン活用力に関する肌の老化に対する抵抗力が決定される、項目20に記載の方法。
[22] 項目1~21のいずれか一項に記載の方法により決定される抵抗力に応じて、老化に対する予防処置を提案する方法。
[23] 細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる複数の抵抗力を決定し、抵抗力が低いと判定された少なくとも1の抵抗力について対応する予防処置を提案する、項目22に記載の方法。
[24] 肌の老化に対する抵抗力の決定装置であって、
 肌の老化に対する抵抗力に関与する遺伝子についてのSNP情報を入力する入力部、
 予めSNP情報と肌の老化に対する抵抗力との関係を記憶された記憶部、
 入力部から入力されたSNP情報と、予め記憶部に記憶されたSNP情報と肌の老化に対する抵抗力との関係とを比較し、肌の老化に対する抵抗力を決定する処理部、
 決定された肌の老化に対する抵抗力を出力する出力部
 を含む、前記決定装置。
[25] 前記肌の老化に対する抵抗力が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる少なくとも1である、項目24に記載の決定装置。
[26] 細胞アクティブ力に関与する遺伝子が、BLMH、CASP14、及びHAS3からなる群から選ばれる少なくとも1の遺伝子であり、
 肌シールド力に関与する遺伝子が、PLAU(uPA)及びCASP14からなる群から選ばれる少なくとも1の遺伝子であり、
 顔形状モデリング力に関与する遺伝子が、MMP-1、MMP-2、MMP-9、ELN、HAS2、FBLN5、及びCOL1A1、からなる群から選ばれる少なくとも1の遺伝子であり、
 代謝維持力に関与する遺伝子が、VEGFA及びVEGFCからなる群から選ばれる少なくとも1の遺伝子であり、
 肌色アシスト力に関与する遺伝子が、OCA2及びIRF4からなる群から選ばれる少なくとも1の遺伝子であり、
 刺激プロテクト力に関与する遺伝子がSOD2及びGPX1からなる群から選ばれる少なくとも1の遺伝子であり、
 ダメージコントロール力に関与する遺伝子がTNF-α、PLAU(uPA)、及びTNFR2からなる群から選ばれる少なくとも1の遺伝子であり、
 アクアビタミン活用力に関与する遺伝子が血液中のビタミンB2 level及びビタミンB12 levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子であり、 オイルビタミン活用力に関与する遺伝子が血液中のビタミンA level、ビタミンD level、及びビタミンE levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子である、項目25に記載の決定装置。
[27] 細胞アクティブ力に関与する遺伝子についてのSNP情報が、以下の:
rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
 肌シールド力に関与する遺伝子についてのSNP情報が、以下の:
rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
 顔形状モデリング力に関与する遺伝子についてのSNP情報が、以下の:
rs1799750、rs10233395、rs1030868、rs1057297、rs1057308、rs1061237、rs1061947、rs1107946、rs1144391、rs13925、rs13969、rs17576、rs17577、rs17804735、rs17855988、rs17884110、rs1800012、rs1871884、rs2046571、rs2071307、rs2241145、rs2246416、rs2285053、rs2287074、rs2430347、rs2856728、rs4255143、rs4618701、rs470558、rs5854、rs7149187、rs7201、rs77357345、rs8326、及びrs9509からなる群から選ばれる少なくとも1のSNPについての情報であり、
代謝維持力に関与する遺伝子についてのSNP情報が、以下の:
rs1485766、rs10434、rs2010963、rs475106、rs475920、rs510684、rs699947、rs735286、及びrs833061からなる群から選ばれる少なくとも1のSNPについての情報であり、
肌色アシスト力に関与する遺伝子についてのSNP情報が、以下の:
 rs1800414、rs1050975、rs1131442、rs12203592、rs12913832、rs1540771、rs1800404、rs1800411、rs74653330、及びrs872071からなる群から選ばれる少なくとも1のSNPについての情報であり、
刺激プロテクト力に関与する遺伝子についてのSNP情報が、以下の:
rs4880、rs10370、rs1050450、rs1800668、rs3448、rs3811699、rs732498、rs7855、rs8031、及びrs8179164からなる群から選ばれる少なくとも1のSNPについての情報であり、
ダメージコントロール力に関与する遺伝子についてのSNP情報が、以下の:
rs1799724、rs1061622、rs1800629、rs2227564、rs2227566、rs2227568、rs2227574、rs235249、rs3093662、rs3397、rs361525、rs4065、rs472093、rs474247、及びrs673からなる群から選ばれる少なくとも1のSNPについての情報であり、
アクアビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
rs1801133、rs1047781、rs10515552、rs2298585、及びrs3760776からなる群から選ばれる少なくとも1のSNPについての情報であり、
オイルビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
rs10882272、rs11057830、rs11234027、rs12272004、rs12785878、rs12934922、rs1667255、rs1993116、rs2060793、rs2108622、rs2282679、rs7501331、及びrs964184からなる群から選ばれる少なくとも1のSNPについての情報である、項目25又は26に記載の決定装置。
[28] 前記記憶部が、肌の老化に対する抵抗力に応じた予防処置をさらに記憶しており、
 前記処理部が、前記処理部において決定された抵抗力に応じた予防処置を記憶部から読み出し、
 前記出力部が、読み出された予防処置を出力する、項目24~27のいずれか一項に記載の決定装置。
 [29] 前記決定装置の前記処理部が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる複数の抵抗力を決定し、前記決定装置の前記出力部が、抵抗力が低いと判定された少なくとも1の抵抗力について対応する予防処置を出力する、項目28に記載の決定装置。
[30] 入力部、記憶部、処理部、及び出力部を含むコンピュータに肌の老化に対する抵抗力を決定させるプログラムであって、以下の:
 処理部に、入力部から入力された肌の老化に対する抵抗力に関与する遺伝子についてのSNP情報と、予め記憶部に記憶されたSNP情報と肌の老化に対する抵抗力との関係とを比較させ、肌の老化に対する抵抗力を決定させる指令;
 決定された肌の老化に対する抵抗力を出力部から出力する指令
 を含む、前記プログラム。
[31] 前記肌の老化に対する抵抗力が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる少なくとも1である、項目30に記載の前記プログラム。
[32] 細胞アクティブ力に関与する遺伝子が、BLMH、CASP14、及びHAS3からなる群から選ばれる少なくとも1の遺伝子であり、
 肌シールド力に関与する遺伝子が、PLAU(uPA)及びCASP14からなる群から選ばれる少なくとも1の遺伝子であり、
 顔形状モデリング力に関与する遺伝子が、MMP-1、MMP-2、MMP-9、ELN、HAS2、FBLN5、及びCOL1A1、からなる群から選ばれる少なくとも1の遺伝子であり、
 代謝維持力に関与する遺伝子が、VEGFA及びVEGFCからなる群から選ばれる少なくとも1の遺伝子であり、
 肌色アシスト力に関与する遺伝子が、OCA2及びIRF4からなる群から選ばれる少なくとも1の遺伝子であり、
 刺激プロテクト力に関与する遺伝子がSOD2及びGPX1からなる群から選ばれる少なくとも1の遺伝子であり、
 ダメージコントロール力に関与する遺伝子がTNF-α、PLAU(uPA)、及びTNFR2からなる群から選ばれる少なくとも1の遺伝子であり、
 アクアビタミン活用力に関与する遺伝子が血液中のビタミンB2 level及びビタミンB12 levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子であり、
 オイルビタミン活用力に関与する遺伝子が 血液中のビタミンA level、ビタミンD level、及びビタミンE levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子である、項目31に記載の前記プログラム。
[33] 細胞アクティブ力に関与する遺伝子についてのSNP情報が、以下の:
rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
 肌シールド力に関与する遺伝子についてのSNP情報が、以下の:
rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
 顔形状モデリング力に関与する遺伝子についてのSNP情報が、以下の:
rs1799750、rs10233395、rs1030868、rs1057297、rs1057308、rs1061237、rs1061947、rs1107946、rs1144391、rs13925、rs13969、rs17576、rs17577、rs17804735、rs17855988、rs17884110、rs1800012、rs1871884、rs2046571、rs2071307、rs2241145、rs2246416、rs2285053、rs2287074、rs2430347、rs2856728、rs4255143、rs4618701、rs470558、rs5854、rs7149187、rs7201、rs77357345、rs8326、及びrs9509からなる群から選ばれる少なくとも1のSNPについての情報であり、
代謝維持力に関与する遺伝子についてのSNP情報が、以下の:
rs1485766、rs10434、rs2010963、rs475106、rs475920、rs510684、rs699947、rs735286、及びrs833061からなる群から選ばれる少なくとも1のSNPについての情報であり、
肌色アシスト力に関与する遺伝子についてのSNP情報が、以下の:
 rs1800414、rs1050975、rs1131442、rs12203592、rs12913832、rs1540771、rs1800404、rs1800411、rs74653330、及びrs872071からなる群から選ばれる少なくとも1のSNP
についての情報であり、
刺激プロテクト力に関与する遺伝子についてのSNP情報が、以下の:
rs4880、rs10370、rs1050450、rs1800668、rs3448、rs3811699、rs732498、rs7855、rs8031、及びrs8179164からなる群から選ばれる少なくとも1のSNPについての情報であり、
ダメージコントロール力に関与する遺伝子についてのSNP情報が、以下の:
rs1799724、rs1061622、rs1800629、rs2227564、rs2227566、rs2227568、rs2227574、rs235249、rs3093662、rs3397、rs361525、rs4065、rs472093、rs474247、及びrs673からなる群から選ばれる少なくとも1のSNPについての情報であり、
アクアビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
rs1801133、rs1047781、rs10515552、rs2298585、及びrs3760776からなる群から選ばれる少なくとも1のSNPについての情報であり、
オイルビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
rs10882272、rs11057830、rs11234027、rs12272004、rs12785878、rs12934922、rs1667255、rs1993116、rs2060793、rs2108622、rs2282679、rs7501331、及びrs964184からなる群から選ばれる少なくとも1のSNPについての情報である、項目31又は32に記載のプログラム。
[34] 前記プログラムが、以下の:
 前記記憶部に肌の老化に対する抵抗力に応じた予防処置を記憶させる指令、
 前記処理部において決定された抵抗力に応じた予防処置を記憶部から読み出すように前記処理部を作動させる指令、
 前記出力部に、読み出された処置を出力させる指令
 をさらに含む、項目30~33のいずれか一項に記載のプログラム。
[35] 前記プログラムが、コンピュータに細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる複数の抵抗力を決定させる指令、
 出力部に、処理部において抵抗力が低いと判定された少なくとも1の抵抗力について対応する予防処置を出力させる指令
 を含む、項目34に記載のプログラム。
[1] A method for determining the resistance to skin aging based on SNP in a gene involved in the resistance to skin aging.
[2] The method according to item 1, wherein the aging of the skin is selected from aging caused by lifestyle, aging caused by the external environment, and natural aging caused by aging.
[3] The resistance to aging of the skin is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization. The method according to item 1 or 2, wherein the method is at least 1 selected from the group consisting of forces.
[4] An item in which cell active force is determined based on SNP in at least one gene selected from the group consisting of bleomycin hydrolase (BLMH), caspase 14 (CASP14), and hyaluronan synthase 3 (HAS3). The method according to 2 or 3.
[5] The following:
At least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862 determines the resistance to skin aging for cell activity. The method according to item 4.
[6] The method according to item 2 or 3, wherein the skin shielding force is determined based on SNP in at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
[7] The following:
Item 6. The resistance to skin aging with respect to skin shielding is determined by at least one SNP selected from the group consisting of rs2158467, rs2227564, rs2227566, rs2227568, rs2227574, rs3181162, rs4065, rs717309, and rs8110862. Method.
[8] Face shape modeling ability is determined based on SNPs in at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1. Or the method according to 3.
[9] The resistance to skin aging is rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884. Skin for face shape modeling by at least one SNP selected from the group consisting of rs2071307, rs2241145, rs2246416, rs2285053, rs2287074, rs2430347, rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509. 8. The method of item 8, wherein the resistance to aging of the skin is determined.
[10] The method according to item 2 or 3, wherein the metabolic maintenance ability is determined based on SNP in at least one gene selected from the group consisting of VEGFA and VEGFC.
[11] As the resistance to aging of the skin, the following:
10. The SNPs selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061 determine the resistance of skin to aging with respect to metabolic maintenance, according to item 10. Method.
[12] The method according to item 2 or 3, wherein the skin color assisting force is determined based on SNP in at least one gene selected from the group consisting of OCA2 and IRF4.
[13] As the resistance to aging of the skin, the following:
At least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071 determines the resistance to skin aging with respect to skin color assisting power, item 12. The method described.
[14] The method according to item 2 or 3, wherein the stimulus protection force is determined based on the SNP in at least one gene selected from the group consisting of SOD2 and GPX1.
[15] When the resistance to aging of the skin is a stimulus-protecting force, the following:
At least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164 determines the resistance to skin aging with respect to irritation protection, in item 14. The method described.
[16] The method of item 2 or 3, wherein the damage control force is determined based on the SNP in at least one gene selected from the group consisting of TNF-α, PLAU (uPA), and TNFR2.
[17] As the resistance to aging of the skin, the following:
With at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673, for skin aging related to damage control. The method of item 16, wherein the resistance is determined.
[18] The item 2 or 3, wherein the aquavitamin utilization ability is determined based on SNP in at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood. Method.
[19] As the resistance to aging of the skin, the following:
18. The method of item 18, wherein the resistance to skin aging with respect to aquavitamin utilization is determined by at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
[20] Oil vitamin utilization is determined based on SNP in at least one gene selected from the group consisting of genes related to the control of vitamin A level, vitamin D level, and vitamin E level in blood. Or the method according to 3.
[21] As the resistance to aging of the skin, the following:
At least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184 provides resistance to skin aging for oil vitamin utilization. The method according to item 20, which is determined.
[22] A method for proposing preventive measures against aging according to the resistance determined by the method according to any one of items 1 to 21.
[23] Multiple selected from the group consisting of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power. 22. The method of item 22, wherein the resistance is determined and the corresponding preventive action is proposed for at least one resistance determined to be low.
[24] A device for determining the resistance of skin to aging.
Input section for inputting SNP information about genes involved in skin aging resistance,
A storage unit that stores the relationship between SNP information and the resistance of the skin to aging in advance.
A processing unit that compares the SNP information input from the input unit with the relationship between the SNP information stored in the storage unit in advance and the resistance to skin aging, and determines the resistance to skin aging.
The determination device comprising an output unit that outputs a determined resistance to skin aging.
[25] The resistance to aging of the skin is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization. The determination device according to item 24, which is at least one selected from the group consisting of forces.
[26] The gene involved in cell active force is at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
The gene involved in the skin shielding force is at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
The gene involved in face shape modeling ability is at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1.
The gene involved in metabolic maintenance is at least one gene selected from the group consisting of VEGFA and VEGFC.
The gene involved in skin color assisting power is at least one gene selected from the group consisting of OCA2 and IRF4.
The gene involved in stimulus protection is at least one gene selected from the group consisting of SOD2 and GPX1.
The gene involved in damage control is at least one gene selected from the group consisting of TNF-α, PLAU (uPA), and TNFR2.
The gene involved in aquavitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood, and the gene involved in oil vitamin utilization is in the blood. 25. The determination device according to item 25, which is at least one gene selected from the group consisting of genes related to the control of Vitamin A level, Vitamin D level, and Vitamin E level.
[27] SNP information on genes involved in cell active force is as follows:
Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
SNP information about genes involved in skin shielding is as follows:
Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
SNP information about genes involved in face shape modeling ability is as follows:
rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Information about at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509.
SNP information about genes involved in metabolic maintenance is as follows:
Information about at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061.
SNP information about genes involved in skin color assisting power is as follows:
Information about at least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071.
SNP information about genes involved in stimulus protection is as follows:
Information about at least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164.
SNP information about genes involved in damage control is as follows:
Information about at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673.
SNP information on genes involved in aquavitamin utilization is as follows:
Information about at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
SNP information on genes involved in oil-vitamin utilization is as follows:
The decision according to item 25 or 26, which is information about at least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184. Device.
[28] The memory unit further memorizes preventive measures according to the resistance of the skin to aging.
The processing unit reads out the preventive measures according to the resistance determined in the processing unit from the storage unit.
The determination device according to any one of items 24 to 27, wherein the output unit outputs the read preventive action.
[29] The processing unit of the determination device has cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization. 28. Item 28, wherein a plurality of resistances selected from the group consisting of forces are determined, and the output unit of the determination device outputs a corresponding preventive measure for at least one resistance determined to have low resistance. Determination device.
[30] A program that causes a computer including an input unit, a storage unit, a processing unit, and an output unit to determine the resistance to skin aging, and is described as follows:
The processing unit is made to compare the SNP information about the genes involved in the resistance to skin aging input from the input unit with the relationship between the SNP information previously stored in the storage unit and the resistance to skin aging. A command that determines the resistance of the skin to aging;
The program comprising a command to output the determined resistance to skin aging from the output unit.
[31] The resistance to aging of the skin is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization. The program according to item 30, wherein the program is at least one selected from the group consisting of forces.
[32] The gene involved in cell active force is at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
The gene involved in the skin shielding force is at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
The gene involved in face shape modeling ability is at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1.
The gene involved in metabolic maintenance is at least one gene selected from the group consisting of VEGFA and VEGFC.
The gene involved in skin color assisting power is at least one gene selected from the group consisting of OCA2 and IRF4.
The gene involved in stimulus protection is at least one gene selected from the group consisting of SOD2 and GPX1.
The gene involved in damage control is at least one gene selected from the group consisting of TNF-α, PLAU (uPA), and TNFR2.
The gene involved in aquavitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood.
The program according to item 31, wherein the gene involved in the ability to utilize oil vitamins is at least one gene selected from the group consisting of genes related to the control of vitamin A level, vitamin D level, and vitamin E level in blood. ..
[33] SNP information about genes involved in cell active force is as follows:
Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
SNP information about genes involved in skin shielding is as follows:
Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
SNP information about genes involved in face shape modeling ability is as follows:
rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Information about at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509.
SNP information about genes involved in metabolic maintenance is as follows:
Information about at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061.
SNP information about genes involved in skin color assisting power is as follows:
At least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071.
Information about
SNP information about genes involved in stimulus protection is as follows:
Information about at least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164.
SNP information about genes involved in damage control is as follows:
Information about at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673.
SNP information on genes involved in aquavitamin utilization is as follows:
Information about at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
SNP information on genes involved in oil-vitamin utilization is as follows:
The program according to item 31 or 32, which is information about at least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184. ..
[34] The program is as follows:
A command to memorize preventive measures according to the resistance of the skin to aging in the memory unit,
A command to operate the processing unit to read the preventive action according to the resistance determined in the processing unit from the storage unit,
The program according to any one of items 30 to 33, further comprising a command to output the read action to the output unit.
[35] The program consists of a computer with cell activation power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power. A command to determine multiple resistances selected from the group,
34. The program of item 34, comprising a command to output a corresponding preventive action for at least one resistance determined by the processing unit to be low resistance.
 SNP解析の結果を、老化に対する抵抗力という観点で評価することで、遺伝的背景に応じた適切な評価が可能になるとともに、抵抗力を補う適切な予防処置を提案することが可能になる。 By evaluating the results of SNP analysis from the viewpoint of resistance to aging, it is possible to make an appropriate evaluation according to the genetic background and to propose appropriate preventive measures to supplement the resistance.
図1Aは、入力部と、記憶部と、処理部と、出力部とを備えた情報処理装置を模式的に表した図である。図1Bは、情報処理装置がネットワークを介して作動するシステムを模式的に表した図である。FIG. 1A is a diagram schematically showing an information processing apparatus including an input unit, a storage unit, a processing unit, and an output unit. FIG. 1B is a diagram schematically showing a system in which an information processing apparatus operates via a network. 図2A~Bは、本発明の情報処理装置が、プログラムに従って、肌の老化に対する抵抗力を決定するための流れを示す模式図である。2A to 2B are schematic views showing a flow for the information processing apparatus of the present invention to determine the resistance to aging of the skin according to a program. 図2C~Dは、本発明の情報処理装置が、プログラムに従って、肌の老化に対する抵抗力を決定するための流れを示す模式図である。2C to 2D are schematic views showing a flow for the information processing apparatus of the present invention to determine the resistance to aging of the skin according to a program. 図3は、肌状態(シワ)の測定値から、高値側と低値側の一定の割合に属する対象を高値群と低値群とに分類して表示したグラフを示す。FIG. 3 shows a graph in which objects belonging to a certain ratio of the high price side and the low price side are classified into a high price group and a low price group from the measured values of the skin condition (wrinkles). 図4は、肌体質を判定する学習モデルの検証の際に作成された、感度と特異度の関係を示すROC曲線のグラフである。FIG. 4 is a graph of the ROC curve showing the relationship between sensitivity and specificity, which was created when the learning model for determining the skin constitution was verified.
 本発明は、被験者のSNP情報に基づいて、肌の老化に対する抵抗力を決定する方法に関する。被験者のSNP情報としては、肌の老化に対する抵抗力に関与する遺伝子における1又は複数のSNPについての情報を使用することができる。 The present invention relates to a method for determining the resistance of a skin to aging based on the SNP information of a subject. As the SNP information of the subject, information about one or more SNPs in the gene involved in the resistance of the skin to aging can be used.
 肌状態は、加齢により変化し、その肌の老化の程度は遺伝的背景によって影響を受ける。肌状態としては、シミ、シワ、皮膚弾力性、メラニン量、肌の明るさ、黄み、上腕肌色等がそれぞれ老化に伴って変化する。肌の老化に対する抵抗力とは、老化の進行を遅延させる能力を指し、遺伝的背景によって異なる。すなわち、老化の進行には、加齢で代表される日々の生活の中で生体内で引き起こされる変化の蓄積が影響し、また、紫外線や乾燥を代表とする外的な環境要因も影響する。このような内的、外的に肌の老化を促進する影響に対する抵抗力は、遺伝的背景で個人毎に異なっている。したがって、遺伝的背景に基づく肌の老化に対する抵抗力を知ることは、後天的な内的、外的な肌の老化促進因子による影響に対する抵抗力を知ることになる。内的、外的な肌の老化促進因子は幅が広く皮膚に影響するため、肌の応答性に影響する肌老化抵抗力を設定し、個人毎に足し合わせることで、個人の肌の老化に対する抵抗力が決定される。本発明において、被験者のSNP情報に基づいて決定される肌の老化に対する抵抗力は、遺伝的背景に基づく肌の老化に対する抵抗力のことをいう。 The skin condition changes with aging, and the degree of skin aging is affected by the genetic background. As for the skin condition, spots, wrinkles, skin elasticity, melanin amount, skin brightness, yellowing, upper arm skin color, etc. change with aging. The resistance of the skin to aging refers to the ability to delay the progression of aging and depends on the genetic background. That is, the progress of aging is affected by the accumulation of changes caused in the living body in daily life represented by aging, and also by external environmental factors such as ultraviolet rays and dryness. The resistance to such internal and external effects of promoting skin aging varies from individual to individual due to their genetic background. Therefore, knowing the resistance of the skin to aging based on the genetic background means knowing the resistance to the effects of acquired internal and external skin aging-promoting factors. Since the internal and external skin aging-promoting factors have a wide range of effects on the skin, the skin aging resistance that affects the responsiveness of the skin is set and added to each individual to prevent individual skin aging. Resistance is determined. In the present invention, the resistance to skin aging determined based on the SNP information of the subject refers to the resistance to skin aging based on the genetic background.
 肌の老化に影響を及ぼす後天的な要因として、ストレス、食生活の乱れなどの栄養状態などの内的な生活習慣及び紫外線や乾燥を代表とする外部因子が挙げられる。遺伝的背景により評価された肌の老化に対する抵抗力が低い場合に、後天的な環境要因、すなわち生活習慣や外部環境を変化させることで、肌の老化を遅らせることが可能になる。肌の老化に関与する生活習慣としては、食生活、睡眠リズム、運動過度、又は運動不足などが挙げられる。肌の老化に関与する外部環境としては、紫外線、汚染物質、重力、居住空間の温湿度変化等が挙げられる。 Acquired factors that affect skin aging include internal lifestyle habits such as stress and nutritional status such as disordered eating habits, and external factors such as ultraviolet rays and dryness. When the resistance to aging of the skin evaluated by the genetic background is low, it is possible to delay the aging of the skin by changing the acquired environmental factors, that is, the lifestyle and the external environment. Lifestyles involved in skin aging include eating habits, sleep rhythms, excessive exercise, or lack of exercise. Examples of the external environment involved in skin aging include ultraviolet rays, pollutants, gravity, and changes in the temperature and humidity of living spaces.
 SNP解析により、生活習慣に起因する肌の老化に対する抵抗力が低いと判定された場合には、生活習慣の改善を指導することができる。またSNP解析により、外部環境に起因する肌の老化に対する抵抗力が低いと判定された場合、外部環境の影響を弱める予防処置、例えば紫外線ケア、汚染物質への対策、及びマッサージなどの重力に対するケアを行うことができる。このように肌の老化の種類を区分し、その区分された肌の老化に対応する肌の老化に対する抵抗力を評価することで、区分された肌の老化に対して適した処置が可能になる。 If it is determined by SNP analysis that the resistance to skin aging caused by lifestyle is low, improvement of lifestyle can be instructed. In addition, if SNP analysis determines that the resistance to aging of the skin caused by the external environment is low, preventive measures to weaken the influence of the external environment, such as UV care, measures against pollutants, and care against gravity such as massage. It can be performed. By classifying the types of skin aging in this way and evaluating the resistance to skin aging corresponding to the classified skin aging, it is possible to perform appropriate treatments for the classified skin aging. ..
 本発明において、肌の老化に対する抵抗力の決定に関わるSNPとしては、被験者のSNPに関する遺伝情報及び環境情報と、肌状態の測定データとの関係を機械学習することにより設定された肌の老化モデル式において採用されたSNPを使用する。肌の老化モデル式において採用されたSNPから、皮膚科学研究により肌機能に関与する遺伝子を明らかにし、老化抵抗力に関与する遺伝子が選択され、機能別にグループ化される。こうした選択過程を経て選択された遺伝子の機能に影響するSNPは、グループ化された機能に関し肌の老化に対する抵抗力を示すことができる。 In the present invention, the SNP involved in determining the resistance to skin aging is a skin aging model set by machine learning the relationship between the genetic information and environmental information regarding the subject's SNP and the measurement data of the skin condition. The SNP adopted in the formula is used. From the SNP adopted in the skin aging model formula, genes involved in skin function are clarified by dermatological research, genes involved in aging resistance are selected, and groups are grouped by function. SNPs that affect the function of genes selected through this selection process can exhibit resistance to skin aging with respect to grouped functions.
 本発明において用いるSNPとしては、以下の:
 rs1050565、rs8110862、rs2232228、rs2227564、rs1799750、rs7201、rs17577、rs8326、rs2046571、rs2246416、rs1107946、rs2010963、rs1485766、rs1800414、rs1540771、rs4880、rs1050450、rs1799724、rs1061622、rs1801133、rs2298585、rs10882272、rs2282679、rs2108622、rs1552472、rs2158467、rs3785079、rs4065、rs5854、rs2241145、rs9509、rs2071307、rs1057308、rs7149187、rs1057297、rs833061、rs475106、rs74653330、rs12203592、rs7855、rs3448、rs1800629、rs3397、rs1047781、rs1667255、rs11234027、rs964184、rs2129785、rs3181162、rs2232227、rs2227566、rs470558、rs1030868、rs13925、rs2856728、rs1871884、rs2430347、rs1061237、rs699947、rs12913832、rs872071、rs8031、rs1800668、rs361525、rs235249、rs3760776、rs12934922、rs12785878、rs11057830、rs3103308、rs717309、rs3759981、rs2227568、rs1144391、rs2285053、rs13969、rs10233395、rs4255143、rs17804735、rs1061947、rs10434、rs475920、rs1800404、rs1050975、rs10370、rs3811699、rs673、rs472093、rs10515552、rs7501331、rs1993116、rs12272004、rs3190884、rs2227574、rs17884110、rs2287074、rs17576、rs17855988、rs4618701、rs77357345、rs1800012、rs735286、rs510684、rs1800411、rs1131442、rs732498、rs8179164、rs3093662、rs474247、rs2060793、からなる群から選ばれる少なくとも1が使用されうる。列挙されたSNPのうち、評価する肌の老化に対する抵抗力に応じて、任意に選択することができる。
The SNP used in the present invention includes the following:
rs1050565, rs8110862, rs2232228, rs2227564, rs1799750, rs7201, rs17577, rs8326, rs2046571, rs2246416, rs1107946, rs2010963, rs1485766, rs1800414, rs1540771, rs4880, rs1050450, rs1799724, rs1061622, rs1801133 rs2158467, rs3785079, rs4065, rs5854, rs2241145, rs9509, rs2071307, rs1057308, rs7149187, rs1057297, rs833061, rs475106, rs74653330, rs12203592, rs7855, rs3448, rs1800629, rs3397, rs1047781 rs2227566, rs470558, rs1030868, rs13925, rs2856728, rs1871884, rs2430347, rs1061237, rs699947, rs12913832, rs872071, rs8031, rs1800668, rs361525, rs235249, rs3760776, rs12934922, rs12785878, rs11057830, rs3103308437 rs13969, rs10233395, rs4255143, rs17804735, rs1061947, rs10434, rs475920, rs1800404, rs1050975, rs10370, rs3811699, rs673, rs472093, rs10515552, rs7501331, rs1993116, rs12272004, rs3190884, rs2227574, rs17884110 rs1800012, rs735286, rs510684, rs1800411, rs11 At least one selected from the group consisting of 31442, rs732498, rs8179164, rs3093662, rs474247, rs2060793, may be used. From the listed SNPs, it can be arbitrarily selected according to the resistance of the skin to be evaluated to aging.
 本発明の1の態様では、本発明において肌の老化に対する抵抗力は、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選択される少なくとも1の抵抗力である。 In one aspect of the present invention, the resistance to skin aging in the present invention is cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aquavitamin. At least one resistance selected from the group consisting of utilization ability and oil vitamin utilization ability.
 細胞アクティブ力とは、保湿力、抗老化保湿力、細胞ホメオスタシス力、細胞環境維持力、細胞代謝調整力、肌新陳代謝力、肌うるおい力ということもでき、皮膚角層の水分を適切に維持する働きを高める力である。。皮膚角層の水分を適切に保つことで、角層内の酵素の働きが保たれ、皮膚代謝や恒常性が維持される。また、皮膚角層の水分は皮膚の柔軟性にも寄与し、表情ぐせなどによる皮膚表面の形状変化への影響を緩和する。かように重要な皮膚角層の水分は、天然保湿因子(NMF)の産生を高めることで高めることができ、それにより表皮の分化を正常化し、そしてバリア機能を亢進することができる。細胞アクティブ力に関わる遺伝子として、一例としてブレオマイシン水解酵素(BLMH)、カスパーゼ14(CASP14)、及びヒアルロン酸合成酵素3(HAS3)が挙げられる。細胞アクティブ力に関わるSNPとして、以下の:rs1050565、rs1552472、rs2129785、rs3103308、rs3190884、rs8110862、rs2158467、rs3181162、rs717309、rs2158467、rs2232228、rs3785079、rs2232227、rs3759981、rs3785079からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、保湿力に起因する肌の老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000001
Cell active power can be said to be moisturizing power, anti-aging moisturizing power, cell homeostasis power, cell environment maintenance power, cell metabolism regulation power, skin metabolism power, and skin moisturizing power, and properly maintains the water content of the skin stratum corneum. It is a power to enhance work. .. By properly maintaining the water content of the skin stratum corneum, the action of enzymes in the stratum corneum is maintained, and skin metabolism and homeostasis are maintained. Moisture in the stratum corneum also contributes to the softness of the skin and alleviates the effects of facial expression on the shape of the skin surface. Moisture in the stratum corneum, which is so important, can be increased by increasing the production of natural moisturizing factors (NMFs), thereby normalizing epidermal differentiation and enhancing barrier function. Examples of genes involved in cell active force include bleomycin hydrolase (BLMH), caspase 14 (CASP14), and hyaluronan synthase 3 (HAS3). As the SNP related to cell active force, at least one selected from the group consisting of the following: rs1050565, rs1552472, rs2129785, rs3103308, rs3190884, rs8110862, rs2158467, rs3181162, rs717309, rs2158467, rs2232228, rs3785079, rs2232227, rs3759981, rs3785079 is used. Can be done. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine the resistance of the skin to aging due to moisturizing power. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000001
 肌シールド力とは、バリア力、抗老化バリア防御力、肌ラッピング力、肌内部安定化力、肌ゲート力、肌ゲートキープ力ということもでき、皮膚の水分が外部に漏れないようにし、かつ、外部から悪影響を及ぼす物質を容易に入れないようバリア機能を良好に保つ力である。表皮分化を正常にし、角層が正常に構築されることで、バリア機能が良好に保たれる。肌シールド力に関わる遺伝子として、ウロキナーゼ型プラスミノゲンアクチベータ(uPA)、カスパーゼ14(CASP14)が挙げられる。肌シールド力に関わるSNPとして、以下の:rs2227564、rs4065、rs2227566、rs2227568、rs2227574、rs8110862、rs2158467、rs3181162、rs717309、rs2158467からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、バリア機能に関する肌の老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000002
The skin shielding power can also be said to be barrier power, anti-aging barrier defense power, skin wrapping power, skin internal stabilization power, skin gate power, and skin gate keeping power to prevent skin moisture from leaking to the outside. , It is the power to keep the barrier function good so that substances that have an adverse effect from the outside cannot easily enter. By normalizing epidermal differentiation and normally constructing the stratum corneum, the barrier function is maintained well. Examples of genes involved in skin shielding power include urokinase-type plasminogen activator (uPA) and caspase 14 (CASP14). As the SNP related to the skin shielding force, at least one selected from the group consisting of the following: rs2227564, rs4065, rs2227566, rs2227568, rs2227574, rs8110862, rs2158467, rs3181162, rs717309, rs2158467 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine the resistance of the skin to aging with respect to barrier function. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000002
 顔形状モデリング力とは、肌内部構造力、顔シェイプアップ力、ハリアップ力、肌フォーム力ということもでき、抗老化真皮表皮連携力及び抗老化真皮弾性アシスト力を構成要素とする。抗老化真皮表皮連携力とは、肌レイヤーキープ力、肌コミュニケーション力ということもでき、表皮と真皮の境界部にある基底膜を良好に保ち、皮膚の機能を良好にする力のことを言う。また、抗老化真皮弾性アシスト力とは、肌ばね調整力、肌スプリング力ということもでき、肌の弾力性を保つ真皮構造を維持する力である。顔形状モデリング力に関わる遺伝子として、マトリクスメタロプロテイナーゼ-1(MMP-1)、マトリクスメタロプロテイナーゼ-2(MMP-2)、マトリクスメタロプロテイナーゼ-9(MMP-9)、エラスチン(ELN)、ヒアルロン酸合成酵素2(HAS2)、フィブリン5(FBLN5)、及びI型コラーゲン(COL1A1)が挙げられる。顔形状モデリング力に関わるSNPとして、以下の:rs1799750、rs5854、rs470558、rs1144391、rs17884110、rs7201、rs2241145、rs1030868、rs2285053、rs2287074、rs17577、rs9509、rs13925、rs13969、rs17576、rs8326、rs2071307、rs2856728、rs10233395、rs17855988、rs2046571、rs1057308、rs1871884、rs4255143、rs4618701、rs2246416、rs7149187、rs2430347、rs17804735、rs77357345、rs1107946、rs1057297、rs1061237、rs1061947、rs1800012からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、抗老化真皮表皮連携力及び抗老化真皮弾性アシスト力に起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000003
The facial shape modeling force can also be referred to as skin internal structural force, face shape-up force, firmness-up force, and skin foaming force, and its constituent elements are anti-aging dermis epidermis cooperation force and anti-aging dermis elastic assisting force. The anti-aging dermis epidermis cooperation ability can be said to be the ability to keep the skin layer and the ability to communicate with the skin, and refers to the ability to maintain the basement membrane at the boundary between the epidermis and the dermis and improve the function of the skin. Further, the anti-aging dermis elastic assist force can be said to be a skin spring adjusting force and a skin spring force, and is a force for maintaining the dermis structure that maintains the elasticity of the skin. Matrix metalloproteinase-1 (MMP-1), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), elastin (ELN), hyaluronan synthase as genes involved in facial shape modeling ability Examples include enzyme 2 (HAS2), fibrin 5 (FBRN5), and type I collagen (COL1A1). SNPs related to face shape modeling ability include: rs1799750, rs5854, rs470558, rs1144391, rs17884110, rs7201, rs2241145, rs1030868, rs2285053, rs2287074, rs17577, rs9509, rs13925, rs13969, rs17576, rs8326, rs2071307, rs2856728, rs. At least one selected from the group consisting of rs17855988, rs2046571, rs1057308, rs1871884, rs4255143, rs4618701, rs2246416, rs7149187, rs2430347, rs17804735, rs77357345, rs1107946, rs1057297, rs1061237, rs1061947, rs1800012 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging due to anti-aging dermal epidermal coordination and anti-aging dermal elastic assisting forces. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000003
 代謝維持力とは、めぐり力、抗老化循環調整力、めぐりサポート力、循環維持力、ホリスティック連携力、肌栄養供給力ということもでき、栄養を補充する血管や老廃物を除去するリンパを良好にする力である。代謝維持力に関わる遺伝子として、血管内皮増殖因子A(VEGFA)及び血管内皮増殖因子C(VEGFC)が挙げられる。代謝維持力に関わるSNPとして、以下の:rs2010963、rs833061、rs699947、rs10434、rs735286、rs1485766、rs475106、rs475106、rs475920、rs510684からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、血管やリンパに起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000004
Metabolism maintenance power can also be said to be circulation power, anti-aging circulation regulation power, circulation support power, circulation maintenance power, holistic cooperation power, skin nutrition supply power, and lymph that removes blood vessels and waste products that supplement nutrition. It is the power to improve. Examples of genes involved in metabolic maintenance include vascular endothelial growth factor A (VEGFA) and vascular endothelial growth factor C (VEGFC). As the SNP involved in metabolic maintenance, at least one selected from the group consisting of the following: rs2010963, rs833061, rs699947, rs10434, rs735286, rs1485766, rs475106, rs475106, rs475920, rs510684 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging caused by blood vessels and lymph. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000004
 肌色アシスト力とは、肌色調整力、抗老化肌色調整力、UVフィルター力、肌色維持力、紫外線応答力、光老化対応力ともいうことができ、皮膚において天然の紫外線防御機能を持つメラニンを高く保つ力である。肌色アシスト力に関わる遺伝子として、眼皮膚白皮症II型(OCA2)、インターフェロン制御因子(IRF4)が挙げられる。肌色アシスト力に関わるSNPとして、以下の:rs1800414、rs74653330、rs12913832、rs1800404、rs1800411、rs1540771、rs12203592、rs872071、rs1050975、rs1131442からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、メラニンに起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000005
Skin color assist power can also be said to be skin color adjustment power, anti-aging skin color adjustment power, UV filter power, skin color maintenance power, UV response power, photoaging response power, and high melanin, which has a natural UV protection function in the skin. It is the power to keep. Genes involved in skin color assisting power include oculocutaneous albinism type II (OCA2) and interferon regulator (IRF4). As the SNP related to the skin color assisting power, at least one selected from the group consisting of the following: rs1800414, rs74653330, rs12913832, rs1800404, rs1800411, rs1540771, rs12203592, rs872071, rs1050975, rs1131442 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to melanin-induced aging. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000005
 刺激プロテクト力とは、抗酸化力、抗老化酸化力、刺激消去力、刺激鎮静化力、ダメージ遮断力、ダメージ吸収力ということもでき、皮膚において発生した活性酸素を無毒化して除去する力である。活性酸素は、細胞内においてスーパーオキシドディスムターゼやグルタチオンペルオキシダーゼなどの酵素の作用により除去される。刺激プロテクト力に関わる遺伝子として、スーパーオキシドディスムターゼ-2(SOD2)、グルタチオンペルオキシダーゼ1(GPX1)が挙げられる。刺激プロテクト力に関わるSNPとして、以下の:rs4880、rs7855、rs8031、rs10370、rs732498、rs1050450、rs3448、rs1800668、rs3811699、rs8179164からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、抗老化酸化力に起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000006
The stimulus protection power can also be said to be antioxidant power, anti-aging oxidative power, stimulus scavenging power, stimulus sedative power, damage blocking power, and damage absorbing power, and is the power to detoxify and remove active oxygen generated in the skin. be. Reactive oxygen species are removed intracellularly by the action of enzymes such as superoxide dismutase and glutathione peroxidase. Examples of genes involved in stimulus protection include superoxide dismutase-2 (SOD2) and glutathione peroxidase 1 (GPX1). As the SNP related to the stimulus protection power, at least one selected from the group consisting of the following: rs4880, rs7855, rs8031, rs10370, rs732498, rs1050450, rs3448, rs1800668, rs3811699, rs8179164 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging due to anti-aging oxidative power. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000006
 ダメージコントロール力とは、炎症調整力、抗老化抗炎症力、炎症コントロール力、肌内部鎮静化力、ダメージ消火力、肌攻撃調整力ということもでき、皮膚において炎症性因子を低下又は産生抑制する力である。炎症性因子を低下させることで、炎症を抑制することができる。ダメージコントロール力に関わる遺伝子として、腫瘍壊死因子α(TNFα)、ウロキナーゼ型プラスミノーゲン活性化因子(PLAU(uPA))、腫瘍壊死因子受容体2(TNFR2)が挙げられる。ダメージコントロール力に関わるSNPとして、以下の:rs1799724、rs1800629、rs361525、rs673、rs3093662、rs2227564、rs4065、rs2227566、rs2227568、rs2227574、rs1061622、rs3397、rs235249、rs472093、rs474247からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、炎症に起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000007
The damage control power can also be said to be inflammation control power, anti-aging anti-inflammatory power, inflammation control power, skin internal calming power, damage fire extinguishing power, and skin attack control power, and reduces or suppresses the production of inflammatory factors in the skin. It is power. Inflammation can be suppressed by reducing inflammatory factors. Genes involved in damage control ability include tumor necrosis factor α (TNFα), urokinase-type plasminogen activator (PLAU (uPA)), and tumor necrosis factor receptor 2 (TNFR2). As the SNP related to damage control power, at least one selected from the group consisting of the following: rs1799724, rs1800629, rs361525, rs673, rs3093662, rs2227564, rs4065, rs2227566, rs2227568, rs2227574, rs1061622, rs3397, rs235249, rs472093, rs474247 is used. Can be done. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging due to inflammation. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000007
 アクアビタミン活用力とは、抗老化水溶性ビタミンコントロール力、アクアビタミン適正化力、アクアビタミン調整力ということもでき、水溶性ビタミンの血中濃度を正常化する力である。アクアビタミン活用力に関わる遺伝子として、ビタミンB2やビタミンB12の血中レベルのコントロールに影響する遺伝子が挙げられる。アクアビタミン活用力に関わるSNPとして、以下の:rs1801133、rs2298585、rs1047781、rs3760776、rs10515552、rs3760776からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、アクアビタミン血中濃度に起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000008
The ability to utilize aqua vitamins can be said to be anti-aging water-soluble vitamin control ability, aqua vitamin optimization ability, and aqua vitamin adjustment ability, and is the ability to normalize the blood concentration of water-soluble vitamins. Genes involved in aquavitamin utilization include genes that affect the control of blood levels of vitamin B2 and vitamin B12. As the SNP related to the aquavitamin utilization ability, at least one selected from the group consisting of the following: rs1801133, rs2298585, rs1047781, rs3760776, rs10515552, rs3760776 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging due to aquavitamin blood levels. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000008
 オイルビタミン活用力とは、抗老化油溶性ビタミンコントロール力、オイルビタミン適正化力、オイルビタミン調整力ということもでき、脂溶性ビタミンの血中濃度を正常化する力である。オイルビタミン活用力に関わる遺伝子として、ビタミンA,ビタミンD、ビタミンEの血中レベルのコントロールに影響する遺伝子が挙げられる。オイルビタミン活用力に関わるSNPとして、以下の:rs10882272、rs1667255、rs12934922、rs7501331、rs2282679、rs11234027、rs12785878、rs1993116、rs2060793、rs2108622、rs964184、rs11057830、rs12272004からなる群から選ばれる少なくとも1が使用されうる。一の実施態様では、かかるSNPの任意の組み合わせ、場合により全ての組み合わせを用いて、オイルビタミン血中濃度に起因する老化に対する抵抗力を決定することができる。各SNPと遺伝子との関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000009
The ability to utilize oil vitamins can be said to be anti-aging oil-soluble vitamin control ability, oil vitamin optimization ability, and oil vitamin adjustment ability, and is the ability to normalize the blood concentration of fat-soluble vitamins. Genes involved in the ability to utilize oil vitamins include genes that affect the control of blood levels of vitamin A, vitamin D, and vitamin E. As the SNP related to the ability to utilize oils and vitamins, at least one selected from the group consisting of the following: rs10882272, rs1667255, rs12934922, rs7501331, rs2282679, rs11234027, rs12785878, rs1993116, rs2060793, rs2108622, rs964184, rs11057830, rs12272004 can be used. In one embodiment, any combination of such SNPs, and optionally all combinations, can be used to determine resistance to aging due to oil vitamin blood levels. The relationship between each SNP and the gene is shown in the table below.
Figure JPOXMLDOC01-appb-T000009
 本発明の別の態様では、以下の:
 SNP情報を入力する入力部、
 予めSNP情報と肌の老化に対する抵抗力との関係を記憶された記憶部、
 入力部から入力されたSNP情報と、予め記憶部に記憶されたSNP情報と肌の老化に対する抵抗力との関係とを比較し、肌の老化に対する抵抗力を決定する処理部、及び
 決定された肌の老化に対する抵抗力を出力する出力部
 を含む、肌の老化に対する抵抗力の決定装置に関する。本発明の決定装置において用いるSNP情報は、本発明の方法で使用されたSNP情報と同一であってもよい。
In another aspect of the invention:
Input section for inputting SNP information,
A storage unit that stores the relationship between SNP information and the resistance of the skin to aging in advance.
A processing unit that determines the resistance to skin aging by comparing the SNP information input from the input unit with the relationship between the SNP information stored in advance in the storage unit and the resistance to skin aging, and the determined unit. It relates to a device for determining the resistance to skin aging, including an output unit that outputs the resistance to skin aging. The SNP information used in the determination device of the present invention may be the same as the SNP information used in the method of the present invention.
 さらに別の態様では、本発明は、以下の:入力部、記憶部、処理部、及び出力部を含む、コンピュータに肌の老化に対する抵抗力を決定させるプログラムであって、以下の:
 処理部に、入力部から入力されたSNP情報と、予め記憶部に記憶されたSNP情報と肌の老化に対する抵抗力との関係とを比較させ、肌の老化に対する抵抗力を決定させる指令;及び
 決定された肌の老化に対する抵抗力を出力部から出力する指令
 を含む、プログラムにも関する。本発明のプログラムにおいて用いるSNP情報は、本発明の方法で使用されたSNP情報と同一であってもよい。
In yet another aspect, the invention is a program that causes a computer to determine resistance to skin aging, including: input, storage, processing, and output:
A command to have the processing unit compare the relationship between the SNP information input from the input unit, the SNP information stored in the storage unit in advance, and the resistance to skin aging, and determine the resistance to skin aging; It also relates to a program that includes a command to output the determined resistance to skin aging from the output section. The SNP information used in the program of the present invention may be the same as the SNP information used in the method of the present invention.
 本発明の方法、決定装置、及びプログラムにおいて肌の老化に対する抵抗力を決定するにあたり、各老化に対する抵抗力についてそれぞれ選択されたSNP毎に、遺伝子型(メジャーホモ型:Homo1、ヘテロ型:Hetero、マイナーホモ型:Homo2)に基づいてスコアを決定することができる。各遺伝子のSNPにおけるメジャーホモ型(Homo1)と、表現型と、遺伝モデルについての対応関係は下記表のとおりである。
Figure JPOXMLDOC01-appb-T000010
In determining the resistance to aging of the skin in the method, determination device, and program of the present invention, the genotype (major homotype: Homo1, heterotype: Hetero,) was selected for each SNP for each resistance to aging. Minor homozygotes: Scores can be determined based on Homo2). The table below shows the correspondence between major homozygotes (Homo1), phenotypes, and genetic models of each gene in SNP.
Figure JPOXMLDOC01-appb-T000010
 ある遺伝子のSNPが、メジャーホモ型で抵抗力を高める場合には、Homo1:高と表記し、抵抗力を低下させる場合には、Homo1:低と表記する。ヘテロ型については、肌質と遺伝子のSNPとの関連研究で得られた解析結果のうち、肌体質結果を用い、各SNPで選択される4種の遺伝モデル(Dominant, Recessive, Additive, Multiplicative)の頻度を計算し、最も高頻度で現れるモデルを採用する。各モデルにおける抵抗力の強さに応じて任意にスコアを決定することができる。一例として、メジャーホモ型で抵抗力が低下するSNPについて、各遺伝モデルにおける抵抗力は下記表のとおり表され、それぞれスコア化される。
Figure JPOXMLDOC01-appb-T000011
When the SNP of a certain gene is a major homozygous and increases resistance, it is described as Homo1: high, and when it decreases resistance, it is described as Homo1: low. For heterozygotes, four genetic models (Dominant, Recessive, Additive, Multiplicative) selected for each SNP using the skin constitution results among the analysis results obtained in the relationship study between skin quality and gene SNP (Dominant, Recessive, Additive, Multiplicative) Calculate the frequency of and adopt the model that appears most frequently. The score can be arbitrarily determined according to the strength of the resistance in each model. As an example, for SNPs whose resistance is reduced in the major homozygous type, the resistance in each genetic model is expressed as shown in the table below and scored respectively.
Figure JPOXMLDOC01-appb-T000011
 本発明の方法、決定装置、及び/又はプログラムは、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選択される少なくとも1の肌の老化に対する抵抗力について決定することができる。本発明の方法、決定装置、及び/又はプログラムは、上述の肌老化に対する抵抗力のうち、複数の肌老化に対する抵抗力を決定することができる。より好ましくは、2、3、4、5、6、7、8又は9の肌老化に対する抵抗力を決定する。本発明の方法、決定装置、及び/又はプログラムにより決定された老化に対する抵抗力に応じて、老化に対する予防処置を提供することができる。決定された複数の肌の老化に対する抵抗力のうち、より好ましくは、老化に対する抵抗力についてのスコアが低いものから順に選択し、予防処置を提供することができる。スコアが同値である場合には、別途取得されているアンケートの結果に基づいて、選択すべき老化に対する抵抗力を決定することができる。こうして表示された老化に対する抵抗力は、遺伝的に弱い抵抗力であるため、優先的に対策を講じる必要がある。 The method, determination device, and / or program of the present invention has cell active power, skin shielding power, face shape modeling power, metabolic maintenance power, skin color assisting power, stimulus protection power, damage control power, aquavitamin utilization power, and oil. It is possible to determine the resistance to aging of at least one skin selected from the group consisting of vitamin utilization. The method, determination device, and / or program of the present invention can determine the resistance to a plurality of skin aging among the above-mentioned resistance to skin aging. More preferably, it determines the resistance of 2, 3, 4, 5, 6, 7, 8 or 9 to skin aging. Prophylactic measures against aging can be provided depending on the resistance to aging determined by the methods, determination devices, and / or programs of the present invention. Of the plurality of determined skin resistance to aging, more preferably, the one having the lowest score for resistance to aging can be selected in order to provide preventive measures. If the scores are equivalent, the resistance to aging to be selected can be determined based on the results of a separately obtained questionnaire. Since the resistance to aging displayed in this way is genetically weak resistance, it is necessary to take priority measures.
 本発明において、SNPは、rs番号(Reference SNP ID number)で表示されている。各rs番号に対応するSNPの詳細情報(染色体上の位置や変異)については、米国国立生物工学情報センター(NCBI)により管理されており、NCBIのホームページ(http://www.ncbi.nlm.nih.gov/)において参照可能である。 In the present invention, the SNP is represented by an rs number (Reference SNP ID number). Detailed information on SNPs (positions and mutations on chromosomes) corresponding to each rs number is managed by the National Center for Biotechnology Information (NCBI), and is managed by the NCBI homepage ( http://www.ncbi.nlm.). It can be referred to in nih.gov /).
 SNPの検出は、公知である任意の方法で行われてよい。一例として、被験者の生体試料、例えば唾液、血液、粘膜、組織片、毛髪等から、定法に基づき、被験者の核酸を精製し、精製された核酸においてSNPが検出される。したがって、本発明の肌特性の決定方法には、試料調製工程、核酸精製工程がさらに含まれていてもよい。核酸は、DNA又はRNAであってよく、RNAの場合、精製後に逆転写を行い、DNAを調製することが好ましい。SNP検出工程では、精製された核酸においてSNPの検出を可能にする手法であれば、任意の方法を用いることができる。対象となるSNPの位置周辺の配列決定を行って、SNPを検出することもできるし、PCR法をベースとした手法、DNAプローブを用いた手法、質量分析を用いた手法を用いて検出することもできる。PCRをベースとした手法として、SNPタイピング法、TaqMan PCR法、一塩基伸長法、Pyrosequencing法、Exonuclease Cycling Assay法などが挙げられる。DNAプローブを用いた手法としては、DNAチップ法(DNAマイクロアレイ)、Invader法などが挙げられる(網羅的遺伝子多型解析(SNP)日薬理誌、125, 148-152, 2005)。SNPは、連鎖不平衡にある別のSNPを伴うことがある。目的とするSNPと連鎖不平衡にあるSNPを検出することで、目的とするSNPを検出することができる。したがって、本発明において、SNPの検出とは、目的とするSNPを直接検出することに限定されず、連鎖不平衡にあるSNPを検出することで、目的とするSNPを検出することも含まれるものとする。 SNP detection may be performed by any known method. As an example, a subject's nucleic acid is purified from a subject's biological sample such as saliva, blood, mucous membrane, tissue piece, hair, etc. according to a conventional method, and SNP is detected in the purified nucleic acid. Therefore, the method for determining skin characteristics of the present invention may further include a sample preparation step and a nucleic acid purification step. The nucleic acid may be DNA or RNA, and in the case of RNA, it is preferable to perform reverse transcription after purification to prepare DNA. In the SNP detection step, any method can be used as long as it is a method that enables detection of SNP in purified nucleic acid. SNPs can be detected by sequencing around the position of the target SNP, or by using a PCR-based method, a DNA probe method, or a mass spectrometry method. You can also. Examples of PCR-based methods include SNP typing method, TaqMan PCR method, single nucleotide extension method, Pyrosequencing method, and Exonuclease Cycling Assay method. Examples of the method using a DNA probe include a DNA chip method (DNA microarray) and an Invader method (Comprehensive Gene Polymorphism Analysis (SNP) Nikkei Journal, 125, 148-152, 2005). An SNP may be accompanied by another SNP that is in linkage disequilibrium. The target SNP can be detected by detecting the SNP that is in linkage disequilibrium with the target SNP. Therefore, in the present invention, the detection of SNP is not limited to directly detecting the target SNP, but also includes detecting the target SNP by detecting the SNP in linkage disequilibrium. And.
 また、既に配列決定がされた個人の塩基配列に基づきSNPの存在を検出することもできる。この場合、既に決定された塩基配列のデータ内で、SNPの存在する位置の配列を調べることで、SNPの存在を検出できる。したがって、この場合のSNPの検出は、SNP情報が記憶されたコンピュータに、塩基配列データを入力することで行われてもよい。より好ましい態様では、入力は、端末からインターネットを介して入力され、サーバー上でSNPが検出され、インターネットを介して当該端末に検出結果を出力することができる。 It is also possible to detect the presence of SNP based on the base sequence of an individual whose sequence has already been determined. In this case, the presence of the SNP can be detected by examining the sequence at the position where the SNP exists in the data of the base sequence already determined. Therefore, the detection of the SNP in this case may be performed by inputting the base sequence data to the computer in which the SNP information is stored. In a more preferred embodiment, the input is input from the terminal via the Internet, the SNP is detected on the server, and the detection result can be output to the terminal via the Internet.
 図1Aは、入力部11と、記憶部12と、処理部13と、出力部14とを備えた本発明の決定装置の具体的構成を示す。本発明の決定装置は、情報処理装置10であってもよいし、ネットワークを介して情報処理装置10に接続されるシステム20を形成していてもよい(図1B)。システム20は、情報処理装置10とは別に端末30が存在し、ネットワークを介して情報処理装置10と接続される。端末30と情報処理装置10との接続は、有線で接続されていてもよいし、無線で接続されていてもよい。一例として、イントラネットやインターネットを介して接続されていてもよい。 FIG. 1A shows a specific configuration of a determination device of the present invention including an input unit 11, a storage unit 12, a processing unit 13, and an output unit 14. The determination device of the present invention may be the information processing device 10 or may form a system 20 connected to the information processing device 10 via a network (FIG. 1B). In the system 20, a terminal 30 exists separately from the information processing device 10, and is connected to the information processing device 10 via a network. The connection between the terminal 30 and the information processing device 10 may be wired or wireless. As an example, it may be connected via an intranet or the Internet.
 入力部11は、データの入力を可能にする任意のデバイスに関し、さらにインターフェイスを含む。インターフェイスを介して、キーボード、マウス等の操作部、通信部、CD-ROM、DVD-ROM、BD-ROM、メモリースティックなどの外部記憶装置に接続されていてもよい。入力部11を介して情報処理装置に対して情報が入力される。入力部から入力される情報としては、SNP情報の他に、指令などが含まれうる。SNPに関する情報が入力部11から入力されて、記憶部12に記憶されてもよい。SNPについての情報に代えて、対象の遺伝配列情報が、入力部11から入力されてもよく。入力された配列情報は、いったん記憶部12に記憶されてもよいし、そのまま処理部13に送られてもよい。対象の遺伝配列情報は、対象の全ゲノム配列であってもよいし、目的の一部配列のみ、あるいはSNP情報のみであってもよい。操作部を介して、入力部11から処理部13における処理の指示を与えることができる。 The input unit 11 further includes an interface for any device that enables data input. It may be connected to an external storage device such as a keyboard, an operation unit such as a mouse, a communication unit, a CD-ROM, a DVD-ROM, a BD-ROM, or a memory stick via an interface. Information is input to the information processing device via the input unit 11. The information input from the input unit may include a command or the like in addition to the SNP information. Information about the SNP may be input from the input unit 11 and stored in the storage unit 12. Instead of the information about the SNP, the genetic sequence information of the target may be input from the input unit 11. The input sequence information may be temporarily stored in the storage unit 12 or may be sent to the processing unit 13 as it is. The genetic sequence information of the target may be the whole genome sequence of the target, only a partial sequence of interest, or only SNP information. Processing instructions in the processing unit 13 can be given from the input unit 11 via the operation unit.
 記憶部12は、データを記憶する任意のデバイスに関し、例えばRAM、ROM、フラッシュメモリ等のメモリ装置、ハードディスクドライブ等の固定ディスク装置、又はフレキシブルディスク、光ディスク等の可搬用の記憶装置などが挙げられる。記憶部12は、入力部11から入力されたデータ及び指示、コンピュータの各種処理に用いられるプログラム、処理部13による処理結果、データベース、出力部14に出力するフォームなどを記憶する。コンピュータプログラムは、例えばCD-ROM、DVD-ROM等のコンピュータ読み取り可能な記録媒体や、インターネットを介してインストールされてもよい。コンピュータプログラムは、公知のセットアッププログラム等を用いて記憶部12にインストールされる。記憶部12には、SNP情報と肌の老化に対する抵抗力との関係が記憶される。また、肌の老化に対する抵抗力をスコア化するための表又は数式が記憶される。スコアに応じた肌の老化に対する抵抗力に対する予防処置との関係も記憶されてもよい。また、記憶部12には、肌の悩みに対するアンケート結果についての情報を記憶していてもよい。 The storage unit 12 includes, for example, a memory device such as a RAM, ROM, or a flash memory, a fixed disk device such as a hard disk drive, or a portable storage device such as a flexible disk or an optical disk, with respect to any device for storing data. .. The storage unit 12 stores data and instructions input from the input unit 11, programs used for various processing of the computer, processing results by the processing unit 13, a database, a form to be output to the output unit 14, and the like. The computer program may be installed via a computer-readable recording medium such as a CD-ROM or a DVD-ROM, or via the Internet. The computer program is installed in the storage unit 12 using a known setup program or the like. The storage unit 12 stores the relationship between the SNP information and the resistance of the skin to aging. In addition, a table or mathematical formula for scoring the resistance of the skin to aging is stored. The relationship with preventive measures against skin aging resistance according to the score may also be remembered. In addition, the storage unit 12 may store information about the results of a questionnaire regarding skin problems.
 処理部13は、演算処理を行う任意のデバイスであり、通常1又は複数のプロセッサ又はその周辺回路を有する。処理部13は、情報処理装置10の全体的な動作を統括的に制御するものであり、例えば中央演算処理装置(CPU)である。処理部13は、記憶部12に記憶しているプログラムに従って各種の演算処理を実行する。演算処理は処理部13に含まれるプロセッサによりおこなわれる。このプロセッサは、入力部11、記憶部12及び出力部14を制御する機能モジュールを含み、各種の制御を行うことができる。これらの各部は、それぞれ独立した集積回路、マイクロプロセッサ、ファームウェアなどで構成されてもよい。処理部13は、入力部11から入力されたSNPの情報と、記憶部12に記憶されたSNP情報と肌の老化に対する抵抗力との関係を読み出し、肌の老化に対する抵抗力を決定する。抵抗力の決定は、記憶部12に記憶された肌の老化に対する抵抗力をスコア化するための表又は数式を読み出しスコア化することにより決定してもよい。複数の肌の老化に対する抵抗力をスコア化し、所定の数、例えば、1、2、3、又は4個、好ましくは3個のスコアの低い肌の老化に対する抵抗力についての予防処置を、記憶部から読み出して決定することができる。処理部13は、スコアが同一である場合、別途取得されていた肌の悩みに対するアンケートの結果をさらに記憶部12から読み出し、同一スコアの肌の老化に対する抵抗力について、いずれを選択すべきか決定することができる。具体的には肌の悩みとの関連が高い肌の老化に対する抵抗力を選択する。処理部13は、SNPの情報の代わりに、対象の遺伝配列情報が入力された場合に、遺伝配列情報中におけるSNPの存在を検出するように作動することもできる。より具体的に、処理部13は、記憶部12に予め記憶されたSNPの配列情報と、入力部11から入力された対象の配列情報とから、対象の配列情報中におけるSNPの存在を検出することができる。処理部13により検出されたSNPの存在についての情報は、一旦、記憶部12に記憶されてもよい。 The processing unit 13 is an arbitrary device that performs arithmetic processing, and usually has one or a plurality of processors or peripheral circuits thereof. The processing unit 13 comprehensively controls the overall operation of the information processing device 10, and is, for example, a central processing unit (CPU). The processing unit 13 executes various arithmetic processes according to the program stored in the storage unit 12. The arithmetic processing is performed by the processor included in the processing unit 13. This processor includes a functional module that controls an input unit 11, a storage unit 12, and an output unit 14, and can perform various controls. Each of these parts may be composed of independent integrated circuits, microprocessors, firmware, and the like. The processing unit 13 reads out the relationship between the SNP information input from the input unit 11 and the SNP information stored in the storage unit 12 and the resistance to skin aging, and determines the resistance to skin aging. The resistance may be determined by reading out and scoring a table or mathematical formula for scoring the resistance of the skin to aging stored in the storage unit 12. Score the resistance to aging of multiple skins and take preventive measures for the resistance to aging of a given number of, eg, 1, 2, 3, or 4, preferably 3 low-scoring skins. It can be read from and determined. When the scores are the same, the processing unit 13 further reads out the results of the separately acquired questionnaire for skin problems from the storage unit 12, and determines which one should be selected for the resistance to aging of the skin having the same score. be able to. Specifically, select the resistance to skin aging, which is highly related to skin problems. The processing unit 13 can also operate to detect the presence of the SNP in the genetic sequence information when the target genetic sequence information is input instead of the SNP information. More specifically, the processing unit 13 detects the presence of the SNP in the target sequence information from the sequence information of the SNP stored in advance in the storage unit 12 and the target sequence information input from the input unit 11. be able to. Information about the existence of the SNP detected by the processing unit 13 may be temporarily stored in the storage unit 12.
 出力部14は、処理部13による処理の結果を出力可能な任意のデバイス、例えば結果を直接表示する液晶ディスプレイ等の表示装置、プリンタ等の出力手段であり、インターフェイスを含んでいてもよい。インターフェイスを介して、ネットワークを介して出力するための通信部、外部記憶装置に接続されていてもよい。入力部11及び出力部14において用いられる通信部は、情報処理装置をネットワークに接続するためのLANやポート等の通信インターフェイスに関する。出力部14は、処理部13で処理された結果、例えば被験者の肌の老化に対する抵抗力を出力する。さらに、出力部14は被験者の有するSNP情報や、肌の老化に対する抵抗力が低いものについての予防処置を出力する。 The output unit 14 is an arbitrary device capable of outputting the processing result by the processing unit 13, for example, a display device such as a liquid crystal display that directly displays the result, an output means such as a printer, and may include an interface. It may be connected to a communication unit or an external storage device for output via a network via an interface. The communication unit used in the input unit 11 and the output unit 14 relates to a communication interface such as a LAN or a port for connecting an information processing device to a network. The output unit 14 outputs, for example, the resistance to aging of the skin of the subject as a result of the processing by the processing unit 13. Further, the output unit 14 outputs SNP information possessed by the subject and preventive measures for those having low resistance to skin aging.
 出力部14から出力された、肌の老化に対する抵抗力に基づいて、カウンセリングを行うことができる。カウンセリングにおいて、肌の老化に対する抵抗力に応じた予防処置や強化措置を提供することができる。「肌の老化に対する抵抗力に応じた」とは、抵抗力が低い場合に、抵抗力を補うことのできる処置を提供することである。肌の老化に対する抵抗力と、予防処置との関係を予め記憶部12に記憶しておいてもよく、出力部14は肌の老化に対する抵抗力の出力と併せて、予防処置の情報を出力することができる。予防処置としては、化粧料、成分とともに、その使用頻度や使用方法などの美容処置に加えて、生活習慣や外部環境を変化させる処置であってもよい。 Counseling can be performed based on the resistance of the skin to aging output from the output unit 14. In counseling, preventive and strengthening measures can be provided according to the resistance of the skin to aging. "Depending on the resistance of the skin to aging" is to provide a treatment that can supplement the resistance when the resistance is low. The relationship between the resistance to skin aging and the preventive measures may be stored in the storage unit 12 in advance, and the output unit 14 outputs the information on the preventive measures together with the output of the resistance to the skin aging. be able to. As the preventive treatment, in addition to cosmetic treatments such as the frequency and method of use of cosmetics and ingredients, treatments that change lifestyle habits and the external environment may be used.
 本発明の方法、装置又はプログラムにより評価された各肌の老化に対する抵抗力に応じた予防処置を提供することができる。このような予防処置は、化粧品といった直接肌に適用する製品及びその使用方法などの美容処置のみならず、食、睡眠、運動、入浴、精神活動といった行動を含めた提案を行うことができる。細胞アクティブ力が弱いと評価された対象には、細胞アクティブ力を高める処置を提案することができる。このような処置として、角質層の保水力を高める処置、例えばパック、エステなどの美容処置や、保水力を高める製品、加湿器の使用や、血行改善のための運動、保湿に効く瞑想などが挙げられる。肌シールド力が弱いと評価された対象には、肌シールド力を高める処置を提案することができる。このような処置として、アロマなどのストレスを軽減する措置、睡眠時間の見直しや疲労を回復させる製品、ω3オイルやミネラルを多く含む食事、腸活などが挙げられる。顔形状モデリング力が弱いと評価された対象には、顔形状モデリング力を高める処置を提案することができる。このような処置として、マッサージや顔ヨガなどの顔の筋肉運動、コラーゲンドリンクの飲用やたんぱく質を多く含む食事、ブルーライトを避ける製品の使用などが挙げられる。代謝維持力が弱いと評価された対象には、代謝維持力を高める処置を提案することができる。このような処置として、血行を促進させリンパの流れを良くする美容措置、ホットヨガや加圧トレーニングなどの運動、血行を促進するショウガやビタミンA、Eを多く含む食事、むくみを抑える睡眠方法などが挙げられる。肌色アシスト力が弱いと評価された対象には、肌色アシスト力を高める処置を提案することができる。このような処置として、サンスクリーンや日傘などの日焼け防止グッズの使用や光老化を防ぐ緑黄色野菜やナッツ等を多く含む食事、リズムを整える朝の屋内日光浴などが挙げられる。刺激プロテクト力が弱いと評価された対象には、刺激プロテクト力を高める処置を提案することができる。このような処置として、抗酸化効果のある化粧品、ポリフェノールやビタミンCを多く含む食事、全身の防御力を上げるスロージョグやぬるま湯入浴等が挙げられる。ダメージコントロール力が弱いと評価された対象には、ダメージコントロール力を高める処置を提案することができる。このような処置として、抗炎症効果のある化粧品、ターメリックを含む製品の活用や栄養バランスの整った食事、全身筋肉の衰えを予防する10分エクササイズが挙げられる。アクアビタミン活用力が弱いと評価された対象には、アクアビタミン活用力を高める処置を提案することができる。このような処置として、ビタミン誘導体を含む化粧品やサプリメント、豚肉料理、自律神経の整え方やモニタリング、運動後の効果的なビタミン摂取方法などが挙げられる。及びオイルビタミン活用力が弱いと評価された対象には、オイルビタミン活用力を高める処置を提案することができる。このような処置として、βカロテンのサプリメントや果物、魚やキノコ類を活用した食事、正しい日光浴の方法、花粉症や大気汚染を避けるグッズの提案が挙げられる。 It is possible to provide preventive measures according to the resistance of each skin to aging evaluated by the method, device or program of the present invention. Such preventive measures can be proposed not only for cosmetics and other cosmetic treatments that are directly applied to the skin and how to use them, but also for behaviors such as food, sleep, exercise, bathing, and mental activity. For subjects evaluated to have weak cell activity, treatments to increase cell activity can be proposed. Such treatments include cosmetological treatments such as facial masks and beauty treatments, products that enhance water retention, use of humidifiers, exercise to improve blood circulation, and meditation that is effective for moisturizing. Can be mentioned. For subjects evaluated as having weak skin shielding power, treatments to enhance skin shielding power can be proposed. Such measures include measures to reduce stress such as aroma, products for reviewing sleep time and recovery from fatigue, diets rich in ω3 oil and minerals, and intestinal activity. For subjects evaluated as having weak face shape modeling ability, it is possible to propose a procedure for enhancing face shape modeling ability. Such procedures include facial muscle exercises such as massage and face yoga, drinking collagen drinks, protein-rich diets, and the use of products that avoid blue light. For subjects evaluated as having weak metabolic maintenance ability, treatments to enhance metabolic maintenance ability can be proposed. Such treatments include cosmetological measures that promote blood circulation and improve lymphatic flow, exercise such as hot yoga and kaatsu training, ginger that promotes blood circulation, a diet rich in vitamins A and E, and sleeping methods that suppress swelling. Can be mentioned. For subjects evaluated as having weak skin color assisting power, it is possible to propose a treatment for enhancing skin color assisting power. Such measures include the use of sunscreen goods such as sunscreens and parasols, meals containing a large amount of green-yellow vegetables and nuts to prevent photoaging, and indoor sun bathing in the morning to adjust the rhythm. For subjects evaluated to have weak stimulus protection, treatments to enhance stimulus protection can be proposed. Examples of such treatment include cosmetics having an antioxidant effect, a diet rich in polyphenols and vitamin C, slow jog that enhances the defense power of the whole body, and bathing in lukewarm water. For subjects who are evaluated as having weak damage control power, it is possible to propose measures to enhance damage control power. Such treatments include the use of anti-inflammatory cosmetics, products containing turmeric, a nutritionally balanced diet, and 10-minute exercises to prevent systemic muscle weakness. For subjects evaluated to have weak aquavitamin utilization, treatments to enhance aquavitamin utilization can be proposed. Such treatments include cosmetics and supplements containing vitamin derivatives, pork dishes, how to prepare and monitor autonomic nerves, and effective vitamin intake methods after exercise. And for subjects evaluated to have weak oil-vitamin utilization, treatments to enhance oil-vitamin utilization can be proposed. Such treatments include β-carotene supplements and fruits, diets that utilize fish and mushrooms, proper sunbathing methods, and suggestions for goods that avoid pollinosis and air pollution.
 本明細書において言及される全ての文献はその全体が引用により本明細書に取り込まれる。 All documents referred to herein are incorporated herein by reference in their entirety.
 以下に説明する本発明の実施例は例示のみを目的とし、本発明の技術的範囲を限定するものではない。本発明の技術的範囲は特許請求の範囲の記載によってのみ限定される。本発明の趣旨を逸脱しないことを条件として、本発明の変更、例えば、本発明の構成要件の追加、削除及び置換を行うことができる。 The examples of the present invention described below are for illustration purposes only and do not limit the technical scope of the present invention. The technical scope of the invention is limited only by the description of the claims. Modifications of the present invention, for example, addition, deletion and replacement of the constituent elements of the present invention may be made on condition that the gist of the present invention is not deviated.
実施例1:解析対象
 20~79歳の女性ボランティア(1448名)を対象とした。解析に先立ち、年齢、身長、体重、BMI(身長と体重から定法に従って算出)、紫外線への暴露情報、及び喫煙情報についてのアンケート調査を行った。紫外線への暴露情報については、現在の日焼け意識を4段階(2段階の日焼け志向、2段階の非日焼け志向)に分類し、さらに、紫外線に対する対応を詳しく把握するため、生まれてから現在まで(1-14歳、15-19歳、20-24歳、25-29歳、及びそれ以降を10年単位で)の日焼け対策を3段階(紫外線対策せず積極的に、強い日差しには紫外線対策、弱い日差しも紫外線対策実施)で分類して調査が行われた。喫煙情報については、喫煙歴無し、過去に1日あたり20本以上の喫煙歴有、過去に1日あたり20本未満の喫煙歴有という3群に分けて調査が行われた。
Example 1: Analysis target Female volunteers (1448) aged 20 to 79 years were targeted. Prior to the analysis, a questionnaire survey was conducted on age, height, weight, BMI (calculated from height and weight according to a standard method), UV exposure information, and smoking information. Regarding exposure information to UV rays, the current tanning consciousness is classified into 4 stages (2 stages of sunburn-oriented, 2 stages of non-tanning-oriented), and in order to grasp the response to UV rays in detail, from birth to the present ( 3 levels of sunburn measures (1-14 years old, 15-19 years old, 20-24 years old, 25-29 years old, and beyond in 10-year increments) (actively without UV protection, UV protection against strong sunlight) , Weak sunlight was also classified by UV protection) and the survey was conducted. The survey was divided into three groups: no smoking history, 20 or more cigarettes per day in the past, and less than 20 cigarettes per day in the past.
実施例2:解析対象における肌実測データの取得
 肌特性値として、20~79歳の女性ボランティアを対象として、肌のシワ状態、シミ状態、肌色(頬メラニン量、明るさ、黄み、上腕内側肌色)、弾力性を計測した。それぞれの測定は、シワ状態とシミ状態はVisia Evolution(Canfield Scientific社製)を用いて、撮影画像から専用の解析法にてシワ、シミのインデックス値(シミ1)を算出するとともに、シミは皮膚画像計測機器によるシミの数(シミ2)、シミ面積(シミ3)も算出し、解析に用いた。肌色は、分光測色計CM-700d(コニカミノルタ社)を用いて解析し、頬のメラニン量(肌色1)、明るさ(L*・測色値)(肌色2)、黄み(b*・測色値)(肌色3)を計測し、さらに上腕内側肌色(肌色4)も測定した。専用の市販機器(Cutometer)を用いて弾力性を測定した。目じりのシワは、さらに、シリコンで皮膚表面のレプリカを作成し、3次元計測して、データをコンピュータに取り込み、独自の解析システムにより画像処理して、シワの最大深さ、体積、面積を算出した。
Example 2: Acquisition of actual skin measurement data in the analysis target As skin characteristic values, wrinkles, stains, and skin colors (cheek melanin amount, brightness, yellowness, inside upper arm) of female volunteers aged 20 to 79 years were targeted. Skin color) and elasticity were measured. For each measurement, using Visia Evolution (manufactured by Canfield Scientific) for the wrinkle state and the spot state, the index value of wrinkles and spots (spot 1) is calculated from the captured image by a dedicated analysis method, and the spot is the skin. The number of stains (stain 2) and the area of stains (stain 3) by the image measuring device were also calculated and used for the analysis. The skin color was analyzed using a spectrophotometer CM-700d (Konica Minolta), and the amount of melanin in the cheeks (skin color 1), brightness (L * / color measurement value) (skin color 2), and yellowness (b *). -Measurement value) (skin color 3) was measured, and the inner skin color of the upper arm (skin color 4) was also measured. The elasticity was measured using a dedicated commercially available device (Cutometer). For wrinkles on the eyes, a replica of the skin surface is made from silicon, three-dimensionally measured, the data is taken into a computer, and image processing is performed using a unique analysis system to calculate the maximum depth, volume, and area of the wrinkles. bottom.
実施例3:解析対象におけるSNPの決定
 解析対象とするSNPは過去の皮膚科学知見から肌特性値への影響が期待される下記の79種を選択した:
rs1800629、rs2108622、rs1047781、rs12203592、rs16891982、rs3760776、rs9340799、rs12913832、rs17822931、rs964184、rs1801133、rs2228479、rs10515552、rs10741657、rs10882272、rs11057830、rs11234027、rs12272004、rs12377462、rs12785878、rs12931267、rs1540771、rs1667255、rs1993116、rs2060793、rs2227564、rs2282679、rs2298585、rs3829251、rs41281112、rs4654748、rs492602、rs602662、rs1030868、rs1126643、rs1256062、rs12934922、rs1485766、rs1501299、rs17577、rs1799724、rs1800012、rs1800414、rs2010963、rs2234693、rs2241145、rs2285053、rs2287074、rs2287076、rs2987983、rs3918242、rs4065、rs4252125、rs6152、rs7201、rs74653330、rs7501331、rs8110862、rs8326、rs833061、rs1050565、rs1799750、rs4880、rs1050450、rs6058017、rs1061622、rs2046571、rs2232228、rs3785079、rs2246416、rs1107946、rs11568737、rs41303970、rs12051272、rs182052、rs3865188、rs6810075、rs7799039、rs1137101。
 選択基準は、表皮、基底膜、真皮、皮下脂肪組織、全身(ホルモン、ビタミン等)において機能する因子、酵素、細胞外マトリックスタンパク質等を選択し、その中からSNPをもつ遺伝子を候補として選択した。これらSNPは、皮膚の各種形質に影響している可能性が考えられる。
 次に、上記79種の各SNPについて、劣性モデル、優性モデル、相加モデル、及び相乗モデルからなる4種の遺伝モデルを設定し、79種のSNPについて計316種の遺伝モデルを考慮したSNPを遺伝情報とした。この遺伝情報及び環境情報を説明変数として、Elastic Netを用いて変数選択を実施することで、各SNPについて最適な遺伝モデルを決定した。本発明に係る学習モデルの作成に先立ち、遺伝モデルの決定をすることで、よりSNPによる肌体質の決定の精度があがることが期待される。
Example 3: Determination of SNP in the analysis target The following 79 types of SNPs that are expected to affect the skin characteristic values were selected from the past dermatological findings.
rs1800629, rs2108622, rs1047781, rs12203592, rs16891982, rs3760776, rs9340799, rs12913832, rs17822931, rs964184, rs1801133, rs2228479, rs10515552, rs10741657, rs10882272, rs11057830, rs11234027, rs12272004, rs12377462 rs2227564, rs2282679, rs2298585, rs3829251, rs41281112, rs4654748, rs492602, rs602662, rs1030868, rs1126643, rs1256062, rs12934922, rs1485766, rs1501299, rs17577, rs1799724, rs1800012, rs1800414, rs2010963, rs2234693 rs3918242, rs4065, rs4252125, rs6152, rs7201, rs74653330, rs7501331, rs8110862, rs8326, rs833061, rs1050565, rs1799750, rs4880, rs1050450, rs6058017, rs1061622, rs2046571, rs2232228, rs3785079, rs2246416. rs3865188, rs6810075, rs7799039, rs1137101.
The selection criteria were epidermis, basement membrane, dermis, panniculus adipos, factors that function in the whole body (hormones, vitamins, etc.), enzymes, extracellular matrix proteins, etc., and genes with SNP were selected as candidates. .. It is possible that these SNPs affect various skin traits.
Next, for each of the above 79 types of SNPs, 4 types of genetic models consisting of a recessive model, a dominant model, an additive model, and a synergistic model are set, and for 79 types of SNPs, a total of 316 types of genetic models are considered. Was used as genetic information. By using this genetic information and environmental information as explanatory variables and performing variable selection using Elastic Net, the optimal genetic model for each SNP was determined. By determining the genetic model prior to the creation of the learning model according to the present invention, it is expected that the accuracy of determining the skin constitution by SNP will be improved.
 解析対象におけるSNPの決定においては、検体として唾液を用いた。唾液はOragene(登録商標) DNA OG-500(DNA Genotek Inc.)を用いて採取し、DNAを安定化させた。唾液よりDNAを精製し、DNAアレイを用い、SNPを決定し、予め選択した上記の79種のSNPの情報を取得した。 Saliva was used as a sample in determining the SNP in the analysis target. Saliva was collected using Oragene® DNA OG-500 (DNA Genotek Inc.) to stabilize the DNA. DNA was purified from saliva, SNPs were determined using a DNA array, and information on the above 79 types of SNPs selected in advance was obtained.
実施例4:高値群と非高値群(又は低値群と非低値群)とに分類し、分類結果を目的変数とした肌体質を判定する学習モデルの作成
 シワ、シミ(シミ1~3)、頬メラニン量(肌色1)、明るさ(肌色2)、黄み(肌色3)、上腕内側肌色(肌色4)、弾力性、シワ面積、シワ体積、シワ最大深さからなる群から選ばれる肌状態の測定値肌状態の測定値に基づいて、肌状態の高値群及び低値群をそれぞれの測定値の分布から年代ごとに決定した。具体的には、肌体質のなり易さ(例えば、対象となる肌体質がシミの場合は、シミのでき易さ)を判定する高値群モデルの場合、肌検査により得られた肌の測定値が各年代(年齢の5歳区切りの範囲)に含まれる全データの上位25%である場合を1、それ以外の場合(非高値群)を0と定義した(図3)。また、肌体質のなり難さ(例えば、対象となる肌体質がシミの場合は、シミのでき難さ)を判定する低値群モデルの場合、肌検査によって得られた肌の測定値が各年代(年齢の5歳区切りの範囲)に含まれる全データの下位25%である場合を1、それ以外を0と定義した。
Example 4: Creation of a learning model for classifying into a high-value group and a non-high-value group (or a low-value group and a non-low-value group) and determining the skin constitution using the classification result as an objective variable Wrinkles and stains (stains 1 to 3) ), Cheek melanin amount (skin color 1), brightness (skin color 2), yellowness (skin color 3), upper arm inner skin color (skin color 4), elasticity, wrinkle area, wrinkle volume, wrinkle maximum depth Based on the measured values of the skin condition, the high value group and the low value group of the skin condition were determined for each age group from the distribution of the respective measured values. Specifically, in the case of a high-value group model that determines the susceptibility to skin constitution (for example, if the target skin constitution is blemishes, the susceptibility to spots), the measured value of the skin obtained by the skin inspection. Is defined as 1 when it is the top 25% of all data included in each age group (range of 5 years division of age), and 0 when it is not (non-high value group) (Fig. 3). In addition, in the case of a low-value group model that determines the difficulty of skin constitution (for example, if the target skin constitution is spots, the difficulty of spots), the measured values of the skin obtained by the skin test are each. The case where it is the lower 25% of all the data included in the age (range of 5 years division of age) is defined as 1, and the other cases are defined as 0.
 目的変数として、高値群判定モデルの場合、高値群を1、非高値群を0として、説明変数として79種のSNPについての情報、アンケート結果に基づく環境要因についての情報を入力し、ロジスティック回帰分析を行って、肌体質を判定する学習モデルを作成した。学習モデルの作成において、使用されるSNPの数nとした。n=1~4(m1)と5~10(m2)でそれぞれ作成した。肌体質を判定する学習モデルでは、各説明変数について定数項が決定されており、説明変数を入力することで目的変数である肌体質のなり易さ(肌状態の高値群に属する可能性)及び/又は肌体質のなり難さ(肌状態の低値群に属する可能性)を出力することができる。 In the case of the high price group judgment model, the high price group is set to 1 and the non-high price group is set to 0, and information on 79 types of SNPs and information on environmental factors based on the questionnaire results are input as explanatory variables, and logistic regression analysis is performed. To create a learning model for determining the skin constitution. The number n of SNPs used in creating the learning model was set. It was prepared with n = 1 to 4 (m1) and 5 to 10 (m2), respectively. In the learning model for determining the skin constitution, a constant term is determined for each explanatory variable, and by inputting the explanatory variable, the tendency of the skin constitution to become the objective variable (possibility of belonging to the high value group of the skin condition) and / Or it is possible to output the difficulty of skin constitution (possibility of belonging to the low value group of skin condition).
実施例5:学習モデルの検証
  作成された肌体質を判定する学習モデルに対して、検証データの説明変数を入力することで出力される肌体質のなり易さ(又はなり難さ)と、検証データの肌状態の高値群(又は低値群)への分類に基づいて、ROC曲線を得て、ROC曲線下面積(AUC)及び感度(Sensitivity)を求めた(図4)。感度は、ROC曲線から求められる最適カットオフ値(ROC曲線の左上隅(感度、特異度ともに1となる点)との距離が最小となる点の値など)やROC曲線に依らず設定した値(例えば、予測モデルから得られる肌体質スコアは確率値であるので、カットオフ値を0.5に設定するなど)を用いた。こうして作成された100通りの肌体質を決定する学習モデルにおいて、SNPの出現頻度を調べ、各肌体質(シミ1、シミ2、シミ3、肌色1、肌色2、肌色3、肌色4、シワ、弾力性、シワ面積、シワ体積、シワ最大深さ)を判定する学習モデルで用いられるSNPを下記表に示した。SNPの出現頻度と生化学的知見に基づき、学習モデルに使用されるSNPを選択し、作成された学習モデルのなかから、かかるSNPを利用しつつ、AUCの高い学習モデルを選択した。
Example 5: Verification of learning model For the created learning model for determining the skin constitution, the ease (or difficulty) of the skin constitution output by inputting the explanatory variables of the verification data and the verification. Based on the classification of the data into the high value group (or low value group) of the skin condition, the ROC curve was obtained, and the area under the ROC curve (AUC) and the sensitivity (Sensitivity) were obtained (FIG. 4). Sensitivity is a value set regardless of the optimum cutoff value obtained from the ROC curve (value at the point where the distance from the upper left corner of the ROC curve (point where both sensitivity and specificity are 1) is the minimum, etc.) and the ROC curve. (For example, since the skin constitution score obtained from the prediction model is a probability value, the cutoff value is set to 0.5, etc.) was used. In the learning model that determines the 100 types of skin constitution created in this way, the appearance frequency of SNP is investigated, and each skin constitution (stain 1, stain 2, stain 3, skin color 1, skin color 2, skin color 3, skin color 4, wrinkles, The table below shows the SNPs used in the learning model for determining elasticity, wrinkle area, wrinkle volume, and maximum wrinkle depth. Based on the frequency of appearance of SNPs and biochemical knowledge, the SNPs used for the learning model were selected, and from the created learning models, a learning model with a high AUC was selected while using the SNPs.
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000023
 上で列挙されたSNPは、それぞれ各肌状態に対する老化モデル式に用いられるSNPである。これらのSNPの属する遺伝子の機能面を検討し、肌の老化の抵抗力に関わる遺伝子を確定した。そして、それぞれの遺伝子の機能に影響するSNPを調査し、選択し、表に示した。
Figure JPOXMLDOC01-appb-T000024
The SNPs listed above are the SNPs used in the aging model formula for each skin condition, respectively. The functional aspects of the genes to which these SNPs belong were examined, and the genes involved in skin aging resistance were confirmed. Then, SNPs that affect the function of each gene were investigated, selected, and shown in the table.
Figure JPOXMLDOC01-appb-T000024
 以上のSNPから、特に下記のSNPを、老化抵抗力の評価のために使用した:
Figure JPOXMLDOC01-appb-T000025
From the above SNPs, in particular the following SNPs were used for the evaluation of aging resistance:
Figure JPOXMLDOC01-appb-T000025
実施例6:肌の老化抵抗力の評価
 被験者から取得したSNP情報を取得し、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力のそれぞれについて、各SNPの表現型と遺伝子モデルに基づきスコアを計算した。具体的には、各SNPの表現型について、下記表にしたがいスコアを付した。スコアの低い3つの抵抗力を選択し、被験者に対する予防と抵抗力の強化をお勧めする3力とした。スコアの低い3つの抵抗力に対して、老化に対する予防処置を提案することができる。
Figure JPOXMLDOC01-appb-T000026
Example 6: Evaluation of skin aging resistance Obtaining SNP information acquired from a subject, cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, Scores were calculated for each of the aqua vitamin utilization ability and the oil vitamin utilization ability based on the phenotype and genetic model of each SNP. Specifically, scores were given for each SNP phenotype according to the table below. Three resistances with low scores were selected, and the three resistances recommended for the subject to prevent and strengthen the resistance. Preventive measures against aging can be proposed for the three low-scoring resistances.
Figure JPOXMLDOC01-appb-T000026
実施例7 評価された肌抵抗力の検証
  遺伝子検査の結果から9種の肌の老化に対する抵抗力の強さとバランスを解明し、お客様へ予防と強化をお勧めする3種の肌の老化に対する抵抗力を提案するためのアルゴリズムを開発した。このアルゴリズムについて、被験者(約1500名)の遺伝子検査結果、肌測定結果、肌悩みアンケート結果に基づいてその有効性を検証した。具体的には、被験者の有するSNPについて、前記表25及び表26の定義にしたがい、被験者の各肌の老化に対する抵抗力をスコア化した。また、遺伝子検査結果だけでは3力を定義できない場合に、本発明者らが独自で作成した9種の肌悩みアンケートの結果を用いることで、肌の老化に対する抵抗力の絞り込みに成功した。その一例として、全被験者について、各老化に対する抵抗力のスコアを決定し、各老化に対する抵抗力のスコアの分布を確認したところ、お客様に予防と強化をお勧めする3種の肌の老化に対する抵抗力の決定率が平均83.3%となることを確認した。これにより、本発明者らが新たに開発した本アルゴリズムは、お客様のパーソナライズな肌体質や肌悩みに応じて肌の老化に対する抵抗力のバランス改善を支援する、我々が新たに開発したサービスの中核技術として妥当であることを示している。
Example 7 Verification of evaluated skin resistance Three types of skin aging resistance that we recommend customers to prevent and strengthen by clarifying the strength and balance of nine types of skin resistance to aging from the results of genetic tests. We have developed an algorithm to propose power. The effectiveness of this algorithm was verified based on the genetic test results, skin measurement results, and skin trouble questionnaire results of the subjects (about 1500 persons). Specifically, for the SNPs possessed by the subjects, the resistance of each skin of the subjects to aging was scored according to the definitions in Tables 25 and 26. In addition, when the three powers cannot be defined only by the genetic test results, we succeeded in narrowing down the resistance to skin aging by using the results of nine kinds of skin trouble questionnaires originally created by the present inventors. As an example, we determined the resistance score for each aging for all subjects and confirmed the distribution of the resistance score for each aging. It was confirmed that the power determination rate was 83.3% on average. As a result, this algorithm newly developed by the present inventors supports the improvement of the balance of resistance to skin aging according to the customer's personalized skin constitution and skin troubles, and is the core of the service newly developed by us. It shows that it is appropriate as a technology.
 実施例8:本発明の肌の老化に対する抵抗力の決定方法の有効性を示す実施例
 アクアビタミン活用力が低い(アクアビタミン活用力:1)と判定された60代女性2名、A1及びA2の日常的な水溶性ビタミン摂取量を表27に示す。また、両者のシミの程度を表28に示す。水溶性ビタミンの摂取量が高い被験者の方がシミの量が少ない。このことは、本発明の抵抗力の決定方法の有効性を示しており、抵抗力に添った生活をすることでSNPによる肌老化の影響が軽減される1例である。
Figure JPOXMLDOC01-appb-T000027
Figure JPOXMLDOC01-appb-T000028
Example 8: Example showing the effectiveness of the method for determining the resistance to skin aging of the present invention Two females in their 60s, A1 and A2, who were determined to have low aquavitamin utilization (aquavitamin utilization: 1). The daily intake of water-soluble vitamins is shown in Table 27. Table 28 shows the degree of stains on both sides. Subjects with higher intake of water-soluble vitamins have less stains. This shows the effectiveness of the method for determining the resistance of the present invention, and is an example in which the influence of skin aging due to SNP is reduced by living according to the resistance.
Figure JPOXMLDOC01-appb-T000027
Figure JPOXMLDOC01-appb-T000028

Claims (35)

  1.  肌の老化に対する抵抗力に関与する遺伝子におけるSNPに基づく肌の老化に対する抵抗力を決定する方法。 A method for determining skin aging resistance based on SNPs in genes involved in skin aging resistance.
  2.  前記肌の老化が、生活習慣に起因する老化、外部環境に起因する老化、及び加齢に起因する自然老化から選ばれる、請求項1に記載の方法。 The method according to claim 1, wherein the aging of the skin is selected from aging caused by lifestyle, aging caused by the external environment, and natural aging caused by aging.
  3.  前記肌の老化に対する抵抗力が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる少なくとも1である、請求項1又は2に記載の方法。 The resistance to aging of the skin consists of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power. The method of claim 1 or 2, wherein the method is at least one selected from the group.
  4.  細胞アクティブ力が、BLMH、CASP14、及びHAS3からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method of claim 2 or 3, wherein the cell active force is determined based on the SNP in at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
  5.  前記肌の老化に対する抵抗力として、以下の:
    rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPにより、細胞アクティブ力に関する肌の老化に対する抵抗力が決定される、請求項4に記載の方法。
    As the resistance to the aging of the skin, the following:
    At least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862 determines the resistance to skin aging for cell activity. The method according to claim 4.
  6.  肌シールド力が、PLAU(uPA)及びCASP14からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method according to claim 2 or 3, wherein the skin shielding force is determined based on the SNP in at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
  7.  前記肌の老化に対する抵抗力として、以下の:
    rs2158467、rs2227564、rs2227566、rs2227568、rs2227574、rs3181162、rs4065、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPにより、肌シールド力に関する肌の老化に対する抵抗力が決定される、請求項6に記載の方法。
    As the resistance to the aging of the skin, the following:
    6. Claim 6, wherein at least one SNP selected from the group consisting of rs2158467, rs2227564, rs2227566, rs2227568, rs2227574, rs3181162, rs4065, rs717309, and rs8110862 determines the resistance to skin aging with respect to skin shielding power. the method of.
  8.  顔形状モデリング力が、MMP-1、MMP-2、MMP-9、ELN、HAS2、FBLN5、及びCOL1A1、からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 Face shape modeling power is determined based on SNPs in at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1. The method according to 3.
  9.  前記肌の老化に対する抵抗力として、以下の:
    rs1799750、rs10233395、rs1030868、rs1057297、rs1057308、rs1061237、rs1061947、rs1107946、rs1144391、rs13925、rs13969、rs17576、rs17577、rs17804735、rs17855988、rs17884110、rs1800012、rs1871884、rs2046571、rs2071307、rs2241145、rs2246416、rs2285053、rs2287074、rs2430347、rs2856728、rs4255143、rs4618701、rs470558、rs5854、rs7149187、rs7201、rs77357345、rs8326、及びrs9509からなる群から選ばれる少なくとも1のSNPにより、顔形状モデリング力に関する肌の老化に対する抵抗力が決定される、請求項8に記載の方法。
    As the resistance to the aging of the skin, the following:
    rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Claim that at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509 determines the resistance to skin aging with respect to facial shape modeling ability. 8. The method according to 8.
  10.  代謝維持力が、VEGFA及びVEGFCからなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method according to claim 2 or 3, wherein the metabolic maintenance ability is determined based on SNP in at least one gene selected from the group consisting of VEGFA and VEGFC.
  11.  前記肌の老化に対する抵抗力として、以下の:
    rs1485766、rs10434、rs2010963、rs475106、rs475920、rs510684、rs699947、rs735286、及びrs833061からなる群から選ばれる少なくとも1のSNPにより、代謝維持力に関する肌の老化に対する抵抗力が決定される、請求項10に記載の方法。
    As the resistance to the aging of the skin, the following:
    10. The claim 10, wherein at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061 determines the resistance of skin to aging with respect to metabolic maintenance. the method of.
  12.  肌色アシスト力が、OCA2及びIRF4からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method according to claim 2 or 3, wherein the skin color assisting force is determined based on SNP in at least one gene selected from the group consisting of OCA2 and IRF4.
  13.  前記肌の老化に対する抵抗力として、以下の:
    rs1800414、rs1050975、rs1131442、rs12203592、rs12913832、rs1540771、rs1800404、rs1800411、rs74653330、及びrs872071からなる群から選ばれる少なくとも1のSNPにより、肌色アシスト力に関する肌の老化に対する抵抗力が決定される、請求項12に記載の方法。
    As the resistance to the aging of the skin, the following:
    Claim 12 that at least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071 determines the resistance to skin aging with respect to skin color assist. The method described in.
  14.  刺激プロテクト力がSOD2及びGPX1からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method according to claim 2 or 3, wherein the stimulus protection force is determined based on the SNP in at least one gene selected from the group consisting of SOD2 and GPX1.
  15.  前記肌の老化に対する抵抗力として、以下の:
    rs4880、rs10370、rs1050450、rs1800668、rs3448、rs3811699、rs732498、rs7855、rs8031、及びrs8179164からなる群から選ばれる少なくとも1のSNPにより、刺激プロテクト力に関する肌の老化に対する抵抗力が決定される、請求項14に記載の方法。
    As the resistance to the aging of the skin, the following:
    14. The method described in.
  16.  ダメージコントロール力がTNF-α、PLAU(uPA)、及びTNFR2からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method according to claim 2 or 3, wherein the damage control force is determined based on SNP in at least one gene selected from the group consisting of TNF-α, PLAU (uPA), and TNFR2.
  17.  前記肌の老化に対する抵抗力として、以下の:
    rs1799724、rs1061622、rs1800629、rs2227564、rs2227566、rs2227568、rs2227574、rs235249、rs3093662、rs3397、rs361525、rs4065、rs472093、rs474247、及びrs673からなる群から選ばれる少なくとも1のSNPにより、ダメージコントロール力に関する肌の老化に対する抵抗力が決定される、請求項16に記載の方法。
    As the resistance to the aging of the skin, the following:
    At least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673 for damage control against skin aging. 16. The method of claim 16, wherein the resistance is determined.
  18.  アクアビタミン活用力が血液中のビタミンB2 level及びビタミンB12 levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 The method according to claim 2 or 3, wherein the aquavitamin utilization ability is determined based on SNP in at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood.
  19.  前記肌の老化に対する抵抗力として、以下の:
    rs1801133、rs1047781、rs10515552、rs2298585、及びrs3760776からなる群から選ばれる少なくとも1のSNPにより、アクアビタミン活用力に関する肌の老化に対する抵抗力が決定される、請求項18に記載の方法。
    As the resistance to the aging of the skin, the following:
    18. The method of claim 18, wherein at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776 determines the resistance to skin aging with respect to aquavitamin utilization.
  20.  オイルビタミン活用力が血液中のビタミンA level、ビタミンD level、及びビタミンE levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子におけるSNPに基づいて決定される、請求項2又は3に記載の方法。 Oil Vitamin utilization is determined based on SNP in at least one gene selected from the group consisting of genes related to control of vitamin A level, vitamin D level, and vitamin E level in blood, claim 2 or 3. The method described in.
  21.  前記肌の老化に対する抵抗力として、以下の:
    rs10882272、rs11057830、rs11234027、rs12272004、rs12785878、rs12934922、rs1667255、rs1993116、rs2060793、rs2108622、rs2282679、rs7501331、及びrs964184からなる群から選ばれる少なくとも1のSNPにより、オイルビタミン活用力に関する肌の老化に対する抵抗力が決定される、請求項20に記載の方法。
    As the resistance to the aging of the skin, the following:
    At least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184 provides resistance to skin aging for oil vitamin utilization. The method of claim 20, as determined.
  22.  請求項1~21のいずれか一項に記載の方法により決定される抵抗力に応じて、老化に対する予防処置を提案する方法。 A method of proposing preventive measures against aging according to the resistance determined by the method according to any one of claims 1 to 21.
  23.  細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる複数の抵抗力を決定し、抵抗力が低いと判定された少なくとも1の抵抗力について対応する予防処置を提案する、請求項22に記載の方法。 Multiple resistances selected from the group consisting of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulation protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power 22. The method of claim 22, wherein a corresponding preventive action is proposed for at least one resistance that has been determined and determined to be low resistance.
  24.  肌の老化に対する抵抗力の決定装置であって、
     肌の老化に対する抵抗力に関与する遺伝子についてのSNP情報を入力する入力部、
     予めSNP情報と肌の老化に対する抵抗力との関係を記憶された記憶部、
     入力部から入力されたSNP情報と、予め記憶部に記憶された予めSNP情報と肌の老化に対する抵抗力との関係とを比較し、肌の老化に対する抵抗力を決定する処理部、
     決定された肌の老化に対する抵抗力を出力する出力部を
     を含む、前記決定装置。
    It is a device that determines the resistance of the skin to aging.
    Input section for inputting SNP information about genes involved in skin aging resistance,
    A storage unit that stores the relationship between SNP information and the resistance of the skin to aging in advance.
    A processing unit that compares the relationship between the SNP information input from the input unit, the SNP information stored in advance in the storage unit, and the resistance to skin aging, and determines the resistance to skin aging.
    The determination device comprising an output unit that outputs a determined resistance to skin aging.
  25.  前記肌の老化に対する抵抗力が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる少なくとも1である、請求項24に記載の決定装置。 The resistance to aging of the skin consists of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power. The determination device according to claim 24, which is at least one selected from the group.
  26.  細胞アクティブ力に関与する遺伝子が、BLMH、CASP14、及びHAS3からなる群から選ばれる少なくとも1の遺伝子であり、
     肌シールド力に関与する遺伝子が、PLAU(uPA)及びCASP14からなる群から選ばれる少なくとも1の遺伝子であり、
     顔形状モデリング力に関与する遺伝子が、MMP-1、MMP-2、MMP-9、ELN、HAS2、FBLN5、及びCOL1A1、からなる群から選ばれる少なくとも1の遺伝子であり、
     代謝維持力に関与する遺伝子が、VEGFA及びVEGFCからなる群から選ばれる少なくとも1の遺伝子であり、
     肌色アシスト力に関与する遺伝子が、OCA2及びIRF4からなる群から選ばれる少なくとも1の遺伝子であり、
     刺激プロテクト力に関与する遺伝子がSOD2及びGPX1からなる群から選ばれる少なくとも1の遺伝子であり、
     ダメージコントロール力に関与する遺伝子がTNF-α、PLAU(uPA)、及びTNFR2からなる群から選ばれる少なくとも1の遺伝子であり、
     アクアビタミン活用力に関与する遺伝子が血液中のビタミンB2 level及びビタミンB12 levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子であり、
     オイルビタミン活用力に関与する遺伝子が血液中のビタミンA level、ビタミンD level、及びビタミンE levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子である、請求項25に記載の決定装置。
    The gene involved in cell active force is at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
    The gene involved in the skin shielding force is at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
    The gene involved in face shape modeling ability is at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1.
    The gene involved in metabolic maintenance is at least one gene selected from the group consisting of VEGFA and VEGFC.
    The gene involved in skin color assisting power is at least one gene selected from the group consisting of OCA2 and IRF4.
    The gene involved in stimulus protection is at least one gene selected from the group consisting of SOD2 and GPX1.
    The gene involved in damage control is at least one gene selected from the group consisting of TNF-α, PLAU (uPA), and TNFR2.
    The gene involved in aquavitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood.
    The determination according to claim 25, wherein the gene involved in the ability to utilize oil vitamins is at least one gene selected from the group consisting of genes related to the control of vitamin A level, vitamin D level, and vitamin E level in blood. Device.
  27.  細胞アクティブ力に関与する遺伝子についてのSNP情報が、以下の:
    rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
     肌シールド力に関与する遺伝子についてのSNP情報が、以下の:
    rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
     顔形状モデリング力に関与する遺伝子についてのSNP情報が、以下の:
    rs1799750、rs10233395、rs1030868、rs1057297、rs1057308、rs1061237、rs1061947、rs1107946、rs1144391、rs13925、rs13969、rs17576、rs17577、rs17804735、rs17855988、rs17884110、rs1800012、rs1871884、rs2046571、rs2071307、rs2241145、rs2246416、rs2285053、rs2287074、rs2430347、rs2856728、rs4255143、rs4618701、rs470558、rs5854、rs7149187、rs7201、rs77357345、rs8326、及びrs9509からなる群から選ばれる少なくとも1のSNPについての情報であり、
    代謝維持力に関与する遺伝子についてのSNP情報が、以下の:
    rs1485766、rs10434、rs2010963、rs475106、rs475920、rs510684、rs699947、rs735286、及びrs833061からなる群から選ばれる少なくとも1のSNPについての情報であり、
    肌色アシスト力に関与する遺伝子についてのSNP情報が、以下の:
     rs1800414、rs1050975、rs1131442、rs12203592、rs12913832、rs1540771、rs1800404、rs1800411、rs74653330、及びrs872071からなる群から選ばれる少なくとも1のSNP
    についての情報であり、
    刺激プロテクト力に関与する遺伝子についてのSNP情報が、以下の:
    rs4880、rs10370、rs1050450、rs1800668、rs3448、rs3811699、rs732498、rs7855、rs8031、及びrs8179164からなる群から選ばれる少なくとも1のSNPについての情報であり、
    ダメージコントロール力に関与する遺伝子についてのSNP情報が、以下の:
    rs1799724、rs1061622、rs1800629、rs2227564、rs2227566、rs2227568、rs2227574、rs235249、rs3093662、rs3397、rs361525、rs4065、rs472093、rs474247、及びrs673からなる群から選ばれる少なくとも1のSNPについての情報であり、
    アクアビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
    rs1801133、rs1047781、rs10515552、rs2298585、及びrs3760776からなる群から選ばれる少なくとも1のSNPについての情報であり、
    オイルビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
    rs10882272、rs11057830、rs11234027、rs12272004、rs12785878、rs12934922、rs1667255、rs1993116、rs2060793、rs2108622、rs2282679、rs7501331、及びrs964184からなる群から選ばれる少なくとも1のSNPについての情報である、請求項25又は26に記載の決定装置。
    SNP information about genes involved in cell active force is as follows:
    Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
    SNP information about genes involved in skin shielding is as follows:
    Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
    SNP information about genes involved in face shape modeling ability is as follows:
    rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Information about at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509.
    SNP information about genes involved in metabolic maintenance is as follows:
    Information about at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061.
    SNP information about genes involved in skin color assisting power is as follows:
    At least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071.
    Information about
    SNP information about genes involved in stimulus protection is as follows:
    Information about at least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164.
    SNP information about genes involved in damage control is as follows:
    Information about at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673.
    SNP information on genes involved in aquavitamin utilization is as follows:
    Information about at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
    SNP information on genes involved in oil-vitamin utilization is as follows:
    25 or 26, which is information about at least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184. Determining device.
  28.  前記記憶部が、肌の老化に対する抵抗力に応じた予防処置をさらに記憶しており、
     前記処理部が、前記処理部において決定された抵抗力に応じた予防処置を記憶部から読み出し、
     前記出力部が、読み出された予防処置を出力する、請求項24~27のいずれか一項に記載の決定装置。
    The memory unit further memorizes preventive measures according to the resistance of the skin to aging.
    The processing unit reads out the preventive measures according to the resistance determined in the processing unit from the storage unit.
    The determination device according to any one of claims 24 to 27, wherein the output unit outputs the read preventive action.
  29.  前記決定装置が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる複数の抵抗力を決定し、前記決定装置の前記出力部が、抵抗力が低いと判定された少なくとも1の抵抗力について対応する予防処置を出力する、請求項28に記載の決定装置。 The determination device is selected from the group consisting of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assisting power, stimulus protection power, damage control power, aquavitamin utilization power, and oil vitamin utilization power. 28. The determination device according to claim 28, wherein a plurality of resistance forces are determined, and the output unit of the determination device outputs a corresponding preventive measure for at least one resistance force determined to have a low resistance force.
  30.  入力部、記憶部、処理部、及び出力部を含むコンピュータに肌の老化に対する抵抗力を決定させるプログラムであって、以下の:
     処理部に、入力部から入力された肌の老化に対する抵抗力に関与する遺伝子についてのSNP情報と、予め記憶部に記憶された予めSNP情報と肌の老化に対する抵抗力との関係とに基づき肌の老化に対する抵抗力を決定させる指令;
     決定された肌の老化に対する抵抗力を出力部から出力する指令
     を含む、前記プログラム。
    A program that allows a computer, including an input unit, a storage unit, a processing unit, and an output unit, to determine the resistance to skin aging, and is described below.
    Skin based on the relationship between the SNP information about the genes involved in the resistance to skin aging input from the input unit to the processing unit, the pre-SNP information stored in the storage unit in advance, and the resistance to skin aging. Command to determine resistance to aging;
    The program comprising a command to output the determined resistance to skin aging from the output unit.
  31.  前記肌の老化に対する抵抗力が、細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる少なくとも1である、請求項30に記載の前記プログラム。 The resistance to aging of the skin consists of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power. 30. The program of claim 30, wherein the program is at least one selected from the group.
  32.  細胞アクティブ力に関与する遺伝子が、BLMH、CASP14、及びHAS3からなる群から選ばれる少なくとも1の遺伝子であり、
     肌シールド力に関与する遺伝子が、PLAU(uPA)及びCASP14からなる群から選ばれる少なくとも1の遺伝子であり、
     顔形状モデリング力に関与する遺伝子が、MMP-1、MMP-2、MMP-9、ELN、HAS2、FBLN5、及びCOL1A1、からなる群から選ばれる少なくとも1の遺伝子であり、
     代謝維持力に関与する遺伝子が、VEGFA及びVEGFCからなる群から選ばれる少なくとも1の遺伝子であり、
     肌色アシスト力に関与する遺伝子が、OCA2及びIRF4からなる群から選ばれる少なくとも1の遺伝子であり、
     刺激プロテクト力に関与する遺伝子がSOD2及びGPX1からなる群から選ばれる少なくとも1の遺伝子であり、
     ダメージコントロール力に関与する遺伝子がTNF-α、PLAU(uPA)、及びTNFR2からなる群から選ばれる少なくとも1の遺伝子であり、
     アクアビタミン活用力に関与する遺伝子が血液中のビタミンB2 level及びビタミンB12 levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子であり、
     オイルビタミン活用力に関与する遺伝子が血液中の ビタミンA level、ビタミンD level、及びビタミンE levelのコントロールに関連する遺伝子からなる群から選ばれる少なくとも1の遺伝子である、請求項31に記載の前記プログラム。
    The gene involved in cell active force is at least one gene selected from the group consisting of BLMH, CASP14, and HAS3.
    The gene involved in the skin shielding force is at least one gene selected from the group consisting of PLAU (uPA) and CASP14.
    The gene involved in face shape modeling ability is at least one gene selected from the group consisting of MMP-1, MMP-2, MMP-9, ELN, HAS2, FBRN5, and COL1A1.
    The gene involved in metabolic maintenance is at least one gene selected from the group consisting of VEGFA and VEGFC.
    The gene involved in skin color assisting power is at least one gene selected from the group consisting of OCA2 and IRF4.
    The gene involved in stimulus protection is at least one gene selected from the group consisting of SOD2 and GPX1.
    The gene involved in damage control is at least one gene selected from the group consisting of TNF-α, PLAU (uPA), and TNFR2.
    The gene involved in aquavitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin B2 level and vitamin B12 level in blood.
    The gene according to claim 31, wherein the gene involved in the oil-vitamin utilization is at least one gene selected from the group consisting of genes related to the control of vitamin A level, vitamin D level, and vitamin E level in blood. program.
  33.  細胞アクティブ力に関与する遺伝子についてのSNP情報が、以下の:
    rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
     肌シールド力に関与する遺伝子についてのSNP情報が、以下の:
    rs1050565、rs1552472、rs2129785、rs2158467、rs2232227、rs2232228、rs3103308、rs3181162、rs3190884、rs3759981、rs3785079、rs717309、及びrs8110862からなる群から選ばれる少なくとも1のSNPについての情報であり、
     顔形状モデリング力に関与する遺伝子についてのSNP情報が、以下の:
    rs1799750、rs10233395、rs1030868、rs1057297、rs1057308、rs1061237、rs1061947、rs1107946、rs1144391、rs13925、rs13969、rs17576、rs17577、rs17804735、rs17855988、rs17884110、rs1800012、rs1871884、rs2046571、rs2071307、rs2241145、rs2246416、rs2285053、rs2287074、rs2430347、rs2856728、rs4255143、rs4618701、rs470558、rs5854、rs7149187、rs7201、rs77357345、rs8326、及びrs9509からなる群から選ばれる少なくとも1のSNPについての情報であり、
    代謝維持力に関与する遺伝子についてのSNP情報が、以下の:
    rs1485766、rs10434、rs2010963、rs475106、rs475920、rs510684、rs699947、rs735286、及びrs833061からなる群から選ばれる少なくとも1のSNPについての情報であり、
    肌色アシスト力に関与する遺伝子についてのSNP情報が、以下の:
     rs1800414、rs1050975、rs1131442、rs12203592、rs12913832、rs1540771、rs1800404、rs1800411、rs74653330、及びrs872071からなる群から選ばれる少なくとも1のSNP
    についての情報であり、
    刺激プロテクト力に関与する遺伝子についてのSNP情報が、以下の:
    rs4880、rs10370、rs1050450、rs1800668、rs3448、rs3811699、rs732498、rs7855、rs8031、及びrs8179164からなる群から選ばれる少なくとも1のSNPについての情報であり、
    ダメージコントロール力に関与する遺伝子についてのSNP情報が、以下の:
    rs1799724、rs1061622、rs1800629、rs2227564、rs2227566、rs2227568、rs2227574、rs235249、rs3093662、rs3397、rs361525、rs4065、rs472093、rs474247、及びrs673からなる群から選ばれる少なくとも1のSNPについての情報であり、
    アクアビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
    rs1801133、rs1047781、rs10515552、rs2298585、及びrs3760776からなる群から選ばれる少なくとも1のSNPについての情報であり、
    オイルビタミン活用力に関与する遺伝子についてのSNP情報が、以下の:
    rs10882272、rs11057830、rs11234027、rs12272004、rs12785878、rs12934922、rs1667255、rs1993116、rs2060793、rs2108622、rs2282679、rs7501331、及びrs964184からなる群から選ばれる少なくとも1のSNPについての情報である、請求項31又は32に記載のプログラム。
    SNP information about genes involved in cell active force is as follows:
    Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
    SNP information about genes involved in skin shielding is as follows:
    Information about at least one SNP selected from the group consisting of rs1050565, rs1552472, rs2129785, rs2158467, rs2232227, rs2232228, rs3103308, rs3181162, rs3190884, rs3759981, rs3785079, rs717309, and rs8110862.
    SNP information about genes involved in face shape modeling ability is as follows:
    rs1799750, rs10233395, rs1030868, rs1057297, rs1057308, rs1061237, rs1061947, rs1107946, rs1144391, rs13925, rs13969, rs17576, rs17577, rs17804735, rs17855988, rs17884110, rs1800012, rs1871884, rs2046571 Information about at least one SNP selected from the group consisting of rs2856728, rs4255143, rs4618701, rs470558, rs5854, rs7149187, rs7201, rs77357345, rs8326, and rs9509.
    SNP information about genes involved in metabolic maintenance is as follows:
    Information about at least one SNP selected from the group consisting of rs1485766, rs10434, rs2010963, rs475106, rs475920, rs510684, rs699947, rs735286, and rs833061.
    SNP information about genes involved in skin color assisting power is as follows:
    At least one SNP selected from the group consisting of rs1800414, rs1050975, rs1131442, rs12203592, rs12913832, rs1540771, rs1800404, rs1800411, rs74653330, and rs872071.
    Information about
    SNP information about genes involved in stimulus protection is as follows:
    Information about at least one SNP selected from the group consisting of rs4880, rs10370, rs1050450, rs1800668, rs3448, rs3811699, rs732498, rs7855, rs8031 and rs8179164.
    SNP information about genes involved in damage control is as follows:
    Information about at least one SNP selected from the group consisting of rs1799724, rs1061622, rs1800629, rs2227564, rs2227566, rs2227568, rs2227574, rs235249, rs3093662, rs3397, rs361525, rs4065, rs472093, rs474247, and rs673.
    SNP information on genes involved in aquavitamin utilization is as follows:
    Information about at least one SNP selected from the group consisting of rs1801133, rs1047781, rs10515552, rs2298585, and rs3760776.
    SNP information on genes involved in oil-vitamin utilization is as follows:
    31 or 32, which is information about at least one SNP selected from the group consisting of rs10882272, rs11057830, rs11234027, rs12272004, rs12785878, rs12934922, rs1667255, rs1993116, rs2060793, rs2108622, rs2282679, rs7501331 and rs964184. program.
  34.  前記プログラムが、以下の:
     前記記憶部に肌の老化に対する抵抗力に応じた処置を記憶させる指令、
     前記処理部において決定された抵抗力に応じた処置を記憶部から読み出すように前記処理部を作動させる指令、
     前記出力部に、読み出された処置を出力させる指令
     をさらに含む、請求項30~33のいずれか一項に記載のプログラム。
    The program is as follows:
    A command to memorize the treatment according to the resistance of the skin to aging in the storage part,
    A command to operate the processing unit to read the treatment according to the resistance determined in the processing unit from the storage unit,
    The program according to any one of claims 30 to 33, further comprising a command to output the read action to the output unit.
  35.  前記プログラムが、コンピュータに細胞アクティブ力、肌シールド力、顔形状モデリング力、代謝維持力、肌色アシスト力、刺激プロテクト力、ダメージコントロール力、アクアビタミン活用力、及びオイルビタミン活用力からなる群から選ばれる複数の抵抗力を決定させる指令、
     出力部に、処理部において抵抗力が低いと判定された少なくとも1の抵抗力について対応する予防処置を出力させる指令
     を含む、請求項34に記載のプログラム。
    The above program is selected from the group consisting of cell active power, skin shielding power, face shape modeling power, metabolism maintenance power, skin color assist power, stimulus protection power, damage control power, aqua vitamin utilization power, and oil vitamin utilization power in the computer. A command to determine multiple resistances,
    34. The program of claim 34, comprising a command to output a corresponding preventive action for at least one resistance determined by the processing unit to be low resistance.
PCT/JP2021/019452 2020-05-22 2021-05-21 Method for determining resistance against skin aging using genetic polymorphism WO2021235551A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022524553A JPWO2021235551A1 (en) 2020-05-22 2021-05-21

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020090033 2020-05-22
JP2020-090033 2020-05-22

Publications (1)

Publication Number Publication Date
WO2021235551A1 true WO2021235551A1 (en) 2021-11-25

Family

ID=78708650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/019452 WO2021235551A1 (en) 2020-05-22 2021-05-21 Method for determining resistance against skin aging using genetic polymorphism

Country Status (2)

Country Link
JP (1) JPWO2021235551A1 (en)
WO (1) WO2021235551A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105861719A (en) * 2016-05-27 2016-08-17 福建爱我健康生物科技有限公司 Primer, probe and kit for evaluating skin anti-aging condition
CN106755390A (en) * 2016-12-15 2017-05-31 上海东方杰玛基因生物科技有限公司 A kind of Primer composition and detection method for skin anti-aging ability genetic test
WO2018101449A1 (en) * 2016-11-30 2018-06-07 株式会社資生堂 Method for analyzing skin characteristics
CN108251521A (en) * 2018-03-15 2018-07-06 北京天平永达科技发展有限公司 For detecting the primer set of tumor susceptibility gene SNP related to skin aging and its application
CN109517906A (en) * 2018-12-29 2019-03-26 上海吉涛生物科技有限公司 A kind of skin anti-aging ability detection method and its detection primer and kit

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105861719A (en) * 2016-05-27 2016-08-17 福建爱我健康生物科技有限公司 Primer, probe and kit for evaluating skin anti-aging condition
WO2018101449A1 (en) * 2016-11-30 2018-06-07 株式会社資生堂 Method for analyzing skin characteristics
CN106755390A (en) * 2016-12-15 2017-05-31 上海东方杰玛基因生物科技有限公司 A kind of Primer composition and detection method for skin anti-aging ability genetic test
CN108251521A (en) * 2018-03-15 2018-07-06 北京天平永达科技发展有限公司 For detecting the primer set of tumor susceptibility gene SNP related to skin aging and its application
CN109517906A (en) * 2018-12-29 2019-03-26 上海吉涛生物科技有限公司 A kind of skin anti-aging ability detection method and its detection primer and kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JORDI NAVAL; VICENTE ALONSO; MIQUEL ANGEL HERRANZ: "Genetic polymorphisms and skin aging: the identification of population genotypic groups holds potential for personalized treatments", CLIN. COSMET. INVESTIG. DERMATOL., vol. 7, 1 January 2014 (2014-01-01), pages 207 - 214, XP055289986, DOI: 10.2147/CCID.S55669 *

Also Published As

Publication number Publication date
JPWO2021235551A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
JP2024028854A (en) Skin characteristics analysis method
US10685739B2 (en) Personalized beauty system
Anestis et al. Anger rumination across forms of aggression
Soares et al. Effects of combined physical exercise training on DNA damage and repair capacity: role of oxidative stress changes
Yusko et al. Risk for excessive alcohol use and drinking-related problems in college student athletes
Anderson et al. Effects of sport pressures on female collegiate athletes: A preliminary longitudinal investigation.
Jang et al. Gender differences in the heritability of seasonal mood change
Brummett et al. NEO personality domains and gender predict levels and trends in body mass index over 14 years during midlife
Hartmann et al. Compensatory beliefs, nutrition knowledge and eating styles of users and non-users of meal replacement products
CN106498071A (en) The system of skin skin quality is detected and is assessed from gene level
WO2021029332A1 (en) Genetic testing method for implementing skin care counseling
Alleles Heterozygous null alleles in filaggrin contribute to clinical dry skin in young adults and the elderly
Wilson et al. Personality and facial morphology: Links to assertiveness and neuroticism in capuchins (Sapajus [Cebus] apella)
Kosma et al. Longitudinal changes in psychosocial constructs and physical activity among adults with physical disabilities
KR20120015359A (en) Computer-aided diagnostic systems and methods for determining skin compositions based on traditional chinese medicinal(tcm) principles
WO2005078448A1 (en) Apparatus for assessing degree of fatigue, method of assessing degree of fatigue and use thereof
US20220051806A1 (en) Counseling method and counseling device
Melikoglu et al. The effect of regular long term training on antioxidant enzymatic activities
Trapé et al. Effect of multicomponent training on blood pressure, nitric oxide, redox status, and physical fitness in older adult women: influence of endothelial nitric oxide synthase (NOS3) haplotypes
Zheng et al. Greater tolerance to losses in sensation seeking: Evidence from probability and delay discounting
WO2021235551A1 (en) Method for determining resistance against skin aging using genetic polymorphism
CN107305598A (en) Individualized skin care products composition analysis device based on congenital skin quality information
Rothstein Dietary fat, coronary heart disease, and cancer: A historical review
Karoui et al. Front-face fluorescence spectroscopy as a rapid and nondestructive tool for differentiating various cereal products: A preliminary investigation
González-Vallejo et al. Analysis of nutrition judgments using the Nutrition Facts Panel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21807562

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022524553

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21807562

Country of ref document: EP

Kind code of ref document: A1